<SEC-DOCUMENT>0001193125-25-020848.txt : 20250205
<SEC-HEADER>0001193125-25-020848.hdr.sgml : 20250205
<ACCEPTANCE-DATETIME>20250205163250
ACCESSION NUMBER:		0001193125-25-020848
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250130
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250205
DATE AS OF CHANGE:		20250205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Walgreens Boots Alliance, Inc.
		CENTRAL INDEX KEY:			0001618921
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				471758322
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36759
		FILM NUMBER:		25593818

	BUSINESS ADDRESS:	
		STREET 1:		108 WILMOT ROAD
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
		BUSINESS PHONE:		(847) 315-2500

	MAIL ADDRESS:	
		STREET 1:		108 WILMOT ROAD
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d896789d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:wba="http://walgreensbootsalliance.com/20250130" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-613">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-01-30_to_2025-01-30">0001618921</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2025-01-30_to_2025-01-30" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2025-01-30_to_2025-01-30">--12-31</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="wba-20250130.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-01-30_to_2025-01-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-30</xbrli:startDate> <xbrli:endDate>2025-01-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-30</xbrli:startDate> <xbrli:endDate>2025-01-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:M3.600WalgreensBootsAllianceInc.NotesDue2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-30</xbrli:startDate> <xbrli:endDate>2025-01-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:M2.125WalgreensBootsAllianceInc.NotesDue2026Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-30</xbrli:startDate> <xbrli:endDate>2025-01-30</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-649">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-01-30_to_2025-01-30" format="ixt:datemonthdayyearen" id="ixv-650">January&#160;30, 2025</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-651">WALGREENS BOOTS ALLIANCE, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-01-30_to_2025-01-30" format="ixt-sec:stateprovnameen" id="ixv-652">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-653">001-36759</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-654">47-1758322</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification Number)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-655">108 Wilmot Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-656">Deerfield</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-01-30_to_2025-01-30" format="ixt-sec:stateprovnameen" id="ixv-657">Illinois</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-658">60015</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-659">(847)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-660">315-3700</ix:nonNumeric></span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-01-30_to_2025-01-30" format="ixt-sec:boolballotbox" id="ixv-661">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-01-30_to_2025-01-30" format="ixt-sec:boolballotbox" id="ixv-662">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-01-30_to_2025-01-30" format="ixt-sec:boolballotbox" id="ixv-663">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-01-30_to_2025-01-30" format="ixt-sec:boolballotbox" id="ixv-664">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Securities Exchange Act of 1934:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-665">Common Stock, $0.01 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-666">WBA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen" id="ixv-667">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member" id="ixv-668">3.600% Walgreens Boots Alliance, Inc. notes due 2025</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member" id="ixv-669">WBA25</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member" format="ixt-sec:exchnameen" id="ixv-670">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member" id="ixv-671">2.125% Walgreens Boots Alliance, Inc. notes due 2026</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member" id="ixv-672">WBA26</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member" format="ixt-sec:exchnameen" id="ixv-673">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-01-30_to_2025-01-30" format="ixt-sec:boolballotbox" id="ixv-674">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">Item</span><span style="text-decoration:underline">&#8201;</span><span style="text-decoration:underline">5.02</span>.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span> </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) of Walgreens Boots Alliance, Inc. (the &#8220;Company&#8221;) held on January&#160;30, 2025, the Company&#8217;s stockholders approved an amendment and restatement of the Walgreens Boots Alliance, Inc. Amended and Restated 2021 Omnibus Incentive Plan (the &#8220;Plan&#8221;), which had been previously approved by the Board of Directors of the Company (the &#8220;Board&#8221;), subject to stockholder approval. The amendment and restatement, among other things, increases the total remaining number of shares available for issuance under the Plan by 61,500,000 shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Plan was described in Proposal 3 of the Company&#8217;s definitive proxy statement filed with the Securities and Exchange Commission on December&#160;13, 2024 in connection with the Annual Meeting (the &#8220;Fiscal 2025 Proxy Statement&#8221;). The descriptions of the Plan contained herein and therein are qualified in their entirety by the full text of the Plan, which is filed as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">Item</span><span style="text-decoration:underline">&#8201;</span><span style="text-decoration:underline">5.03</span>.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</span> </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As disclosed in the Fiscal 2025 Proxy Statement, the Board approved an amendment (the &#8220;Amendment&#8221;) to the Company&#8217;s Amended and Restated Certificate of Incorporation to provide exculpation from liability for certain Company officers in certain circumstances as permitted by Delaware law, subject to stockholder approval at the Annual Meeting. At the Annual Meeting, stockholders considered and approved the Amendment. The Company has filed with the Secretary of State of Delaware a Certificate of Amendment that reflects the Amendment, which was effective upon filing. Following the filing of the Certificate of Amendment, the Company filed with the Secretary of State of Delaware a Restated Certificate of Incorporation that reflects the Amendment, which became effective on February&#160;1, 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Restated Certificate of Incorporation that reflects the approved Amendment is filed as Exhibit 3.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">Item</span><span style="text-decoration:underline">&#8201;</span><span style="text-decoration:underline">5.07</span>.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Submission of Matters to a Vote of Security Holders</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company held the Annual Meeting on January&#160;30, 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Set forth below are the voting results for each of the proposals submitted to a vote of the Company&#8217;s stockholders at the Annual Meeting: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Proposal No.</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;1:</span> The stockholders elected each of the following directors to serve on the Board until the Company&#8217;s next Annual Meeting of Stockholders or until such director&#8217;s respective successor is elected and qualified (or any such director&#8217;s earlier death, resignation or removal): </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:55%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Votes For</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Votes&#160;Against</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Abstentions</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center">Broker<br/>Non-Votes</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Janice M. Babiak</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">506,721,502</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">38,154,028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,209,826</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inderpal S. Bhandari</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">525,949,398</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">18,884,166</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,251,792</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ginger L. Graham</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">503,414,802</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">41,634,606</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,035,948</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bryan C. Hanson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">525,167,272</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">19,879,225</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,038,859</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert L. Huffines</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">531,468,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13,611,902</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,004,704</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valerie B. Jarrett</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">517,388,482</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">27,742,230</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,954,644</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John A. Lederer</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">516,886,052</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">28,128,546</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,070,758</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stefano Pessina</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">521,938,068</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">23,130,642</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,016,646</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas E. Polen</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">512,148,834</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">32,830,419</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,106,103</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nancy M. Schlichting</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">501,476,399</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">43,636,882</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,972,075</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William H. Shrank, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">532,863,826</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,167,978</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,053,552</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Timothy C. Wentworth</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">532,949,525</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,215,868</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,919,963</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">151,130,744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Proposal No.</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;2:</span> The proposal to approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers, as set forth in the Fiscal 2025 Proxy Statement, was approved. There were 494,137,555 votes for, 49,908,008 votes against, and 3,039,793 abstentions. There were 151,130,744 broker <span style="white-space:nowrap">non-votes</span> on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Proposal No.</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;3:</span> The proposal to approve the Walgreens Boots Alliance, Inc. Amended and Restated 2021 Omnibus Incentive Plan was approved. There were 502,677,179 votes for, 41,235,538 votes against, and 3,172,639 abstentions. There were 151,130,744 broker <span style="white-space:nowrap">non-votes</span> on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Proposal No.</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;4:</span> The proposal to approve the Walgreens Boots Alliance, Inc. Employee Stock Purchase Plan, as amended and restated, was approved. There were 533,310,043 votes for, 11,674,621 votes against, and 2,100,692 abstentions. There were 151,130,744 broker <span style="white-space:nowrap">non-votes</span> on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Proposal No.</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;5:</span> The proposal to ratify the appointment of Deloitte&#160;&amp; Touche LLP as the Company&#8217;s independent registered public accounting firm for fiscal year 2025 was approved. There were 660,848,906 votes for, 34,127,508 votes against, and 3,239,686 abstentions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Proposal No.</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;6:</span> The proposal to approve the amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation to provide exculpation from liability for certain Company officers in certain circumstances as permitted by Delaware law was approved. There were 506,567,258 votes for, 37,384,850 votes against, and 3,133,248 abstentions. There were 151,130,744 broker <span style="white-space:nowrap">non-votes</span> on this proposal. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Proposal No.</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;7:</span> The stockholder proposal requesting a report on cigarette waste was not approved. There were 37,541,144 votes for, 503,397,230 votes against, and 6,146,982 abstentions. There were 151,130,744 broker <span style="white-space:nowrap">non-votes</span> on this proposal. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">Item</span><span style="text-decoration:underline">&#8201;</span><span style="text-decoration:underline">9.01</span>.</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Financial Statements and Exhibits</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline">Exhibits</span> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d896789dex31.htm">Restated Certificate of Incorporation of Walgreens Boots Alliance, Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d896789dex101.htm">Walgreens Boots Alliance, Inc. Amended and Restated 2021 Omnibus Incentive Plan </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">SIGNATURE </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:47%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:47%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WALGREENS BOOTS ALLIANCE, INC.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date: February&#160;5, 2025</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joseph B. Amsbary Jr.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph B. Amsbary Jr.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Corporate Secretary</p></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d896789dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTATED CERTIFICATE OF INCORPORATION OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WALGREENS BOOTS ALLIANCE, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Walgreens Boots Alliance, Inc., a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The name of the corporation is Walgreens Boots Alliance, Inc. The date of filing of its original Certificate of
Incorporation with the Secretary of State was September&nbsp;2, 2014. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Restated Certificate of Incorporation was duly adopted in accordance with Section&nbsp;245 of the General
Corporation Law of the State of Delaware, and restates and integrates and does not further amend the provisions of the corporation&#146;s Certificate of Incorporation as theretofore amended and supplemented and there is no discrepancy between the
provisions of the corporation&#146;s Certificate of Incorporation as theretofore amended and supplemented and the provisions of this Restated Certificate of Incorporation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The text of the Certificate of Incorporation of the corporation is hereby integrated and restated in its
entirety as set forth below. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Restated Certificate of Incorporation shall be effective at 12:01 a.m. Eastern Standard Time on
February&nbsp;1, 2025. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, said Walgreens Boots Alliance, Inc. has caused this Restated Certificate of Incorporation to
be signed by Joseph B. Amsbary, Jr., its Senior Vice President, Corporate Secretary this 31<SUP STYLE="font-size:75%; vertical-align:top">st</SUP> day of January, 2025. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>WALGREENS BOOTS ALLIANCE, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joseph B. Amsbary, Jr.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Joseph B. Amsbary, Jr.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Senior Vice President, Corporate Secretary</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name of the corporation (which is hereinafter referred to as the &#147;<U>Corporation</U>&#148;) is: Walgreens Boots Alliance, Inc. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The address
of its registered office in the State of Delaware on the date of this Certificate of Incorporation is: 251 Little Falls Drive, Wilmington, Delaware 19808, New Castle County, and the name of its Registered Agent at said address is: Corporation
Service Company. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the corporation is to engage in any lawful act or activity for which corporations may be organized under the General
Corporation Law of the State of Delaware. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;1</B>.&nbsp;The Corporation shall be authorized to issue 3,232,000,000 shares of capital stock, of which
3,200,000,000 shares shall be shares of Common Stock, par value $0.01 per share (&#147;<U>Common Stock</U>&#148;) and 32,000,000 shares shall be shares of Preferred Stock, par value $0.01 per share (&#147;<U>Preferred Stock</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;2</B>. Shares of Preferred Stock may be issued from time to time in one or more series and/or classes. The Board
of Directors of the Corporation (the &#147;<U>Board</U>&#148;) is hereby authorized to fix the voting rights, if any, designations, powers, preferences and the relative, participation, optional or other rights, if any, and the qualification,
limitations or restrictions thereof, of any unissued series and/or class of Preferred Stock, and to fix the number of shares constituting such series and/or class, and to increase or decrease the number of shares of any such series and/or class (but
not below the number of shares thereof then outstanding). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;3</B>. Except as otherwise provided by law, or by
the resolution or resolutions adopted by the Board designating the rights, powers and preferences of any series and/or class of Preferred Stock, the Common Stock shall have the exclusive right to vote for the election of directors and for all other
purposes, and holders of Preferred Stock shall not be entitled to receive notice of any meeting of stockholders at which they are not entitled to vote. Each share of Common Stock shall have one vote, and the Common Stock shall vote together as a
single class. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless and except to the extent that the <FONT STYLE="white-space:nowrap">By-Laws</FONT> of the Corporation shall so require, the election of
directors of the Corporation need not be by written ballot. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In all elections of directors, every stockholder shall be entitled to as many votes as shall equal the number of votes which (except for this
provision as to cumulative voting) such stockholder would be entitled to cast for the election of directors with respect to such stockholder&#146;s shares of stock multiplied by the number of directors to be elected by such stockholder, and such
stockholder may cast all of such votes for a single director or may distribute them among the number to be voted for, or for any two or more of them as such stockholder may see fit. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The directors and officers of the Corporation shall not be personally liable to the Corporation or to the stockholders of the Corporation for
monetary damages for breach of fiduciary duty as a director or officer, as applicable, except to the extent such exemption from liability or limitation thereof is not permitted under the General Corporation Law of the State of Delaware as the same
exists or may hereafter be amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any repeal or modification of the foregoing paragraph shall not adversely affect any right or
protection of a director or officer of the Corporation existing hereunder with respect to any act or omission occurring prior to such repeal or modification. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
furtherance and not in limitation of the powers conferred by law, the Board of Directors is expressly authorized and empowered to make, alter and repeal the <FONT STYLE="white-space:nowrap">By-Laws</FONT> of the Corporation by a majority vote at any
regular or special meeting of the Board or by written consent, subject to the power of the stockholders of the Corporation to alter or repeal any <FONT STYLE="white-space:nowrap">By-Laws</FONT> made by the Board. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Special
meetings of the stockholders may be called by the Board of Directors, by the President, by the Secretary of the Corporation at the written request of stockholders of record who have, or are acting on behalf of beneficial owners who have, not less
than <FONT STYLE="white-space:nowrap">one-fifth</FONT> of all the outstanding shares entitled to vote generally for the election of directors as of a record date fixed in accordance with the <FONT STYLE="white-space:nowrap">By-Laws</FONT> of the
Corporation, subject to and in accordance with the procedures and requirements set forth in the <FONT STYLE="white-space:nowrap">By-Laws</FONT> of the Corporation, and by such other officers or persons as may be authorized by the <FONT
STYLE="white-space:nowrap">By-Laws</FONT> of the Corporation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation reserves the right at any time from time to time to amend, alter, change or repeal any provision contained in this Certificate
of Incorporation, and any other provisions authorized by the laws of the State of Delaware at the time in force may be added or inserted, in the manner now or hereafter prescribed by law; and all rights, preferences and privileges of whatsoever
nature conferred upon stockholders, directors or any other persons whomsoever by and pursuant to this Certificate of Incorporation in its present form or as hereafter amended are granted subject to the right reserved in this Article. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d896789dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WALGREENS BOOTS ALLIANCE, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED 2021 OMNIBUS INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED ON JANUARY&nbsp;30, 2025 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WALGREENS BOOTS ALLIANCE, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED 2021 OMNIBUS INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">I.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>Background</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">II.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>Purpose</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">III.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">IV.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>Administration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.01</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Authority of the Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.02</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Manner of Exercise of Committee Authority</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.03</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Advisors and Agents of the Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.04</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Records and Reports of the Committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.05</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation of Liability; Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.06</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.07</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Service in More than One Capacity</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">V.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>Shares Subject to Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.01</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Overall Number of Shares Available for Delivery</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.02</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Share Counting Rules</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.03</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director Award Limits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.04</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Adjustments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5.05</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Former Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">VI.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>Eligibility and General Conditions for Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.01</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Eligibility</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.02</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.03</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Award Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.04</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Vesting; Termination of Service</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.05</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Nontransferability of Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.06</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Cancellation and Rescission of Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.07</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stand-Alone, Tandem and Substitute Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.08</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Deferred Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.09</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Additional and Substitute Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interest</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>6.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exemptions from Section&nbsp;16(b) Liability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">VII.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>Specific Provisions for Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.01</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.02</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stock Appreciation Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.03</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Restricted Stock Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.04</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Restricted Stock Units</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.05</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Dividend Equivalents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.06</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Performance Shares and Performance Units</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.07</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Annual Equity Grants, Deferred Stock Units and Deferrals for <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.08</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Bonus Stock and Other Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>7.09</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Cash Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">VIII.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>Performance Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.01</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Performance Awards Generally</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>8.02</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Performance Criteria</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">IX.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>Change in Control</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">X.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>General Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.01</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Additional Award Forfeiture Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.02</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance with Legal and Other Requirements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.03</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Designation of Beneficiary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.04</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.05</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Benefits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.06</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendment and Termination of the Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.07</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Repricing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.08</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Clawback; Right of Setoff</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.09</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Nonexclusivity of the Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Treatment of Awards by Other Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payments in the Event of Forfeitures; Fractional Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Considerations Under Section&nbsp;409A of the Code</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Awards to Participants Outside the United States</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Rights Conferred under Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability; Entire Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.17</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Plan Term</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Gender and Number</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>10.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>General Creditor Status</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WALGREENS BOOTS ALLIANCE, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED 2021 OMNIBUS INCENTIVE PLAN </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>I.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Background </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Walgreens Boots Alliance, Inc., a Delaware corporation (the &#147;Company&#148;), previously maintained the Walgreens Boots Alliance, Inc. 2013
Omnibus Incentive Plan, as amended and restated effective July&nbsp;11, 2017 (the &#147;Former Plan&#148;). On October&nbsp;29, 2020, the Board adopted the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan, as set forth herein (the
&#147;Plan&#148;), to be effective upon and subject to the approval of the Plan by the stockholders of the Company on January&nbsp;28, 2021 (the &#147;Effective Date&#148;). On November&nbsp;24, 2024, the Board amended and restated the Plan to be
effective upon and subject to the approval of the Plan by the stockholders of the Company on January&nbsp;30, 2025 (the &#147;A&amp;R Effective Date&#148;). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>II.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Purpose </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The purpose of the Plan is to aid the Company in attracting, retaining, motivating and rewarding employees,
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors, and other persons who provide substantial services to the Company or its Affiliates, to provide for equitable and competitive compensation opportunities, including deferral
opportunities, to encourage long-term service, to recognize individual contributions and reward achievement of Company goals, and promote the creation of long-term value for stockholders by closely aligning the interests of Participants with those
of stockholders. The Plan authorizes stock-based and cash-based incentives for Participants. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>III.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Definitions </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">In addition to the terms defined in Article I above and elsewhere in the Plan, the following capitalized terms used in the Plan have the
respective meanings set forth in this Section: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Affiliate</B>&#148; means any person with whom the Company would be considered a single
employer under Sections 414(b) and 414(c) of the Code, except that in applying Sections 1563(a)(1), (2) and (3)&nbsp;of the Code for purposes of determining a controlled group of corporations under Section&nbsp;414(b) of the Code, the language
&#147;at least 50 percent&#148; shall be used instead of &#147;at least 80 percent&#148; in each place it appears in Sections 1563(a)(1), (2) and (3)&nbsp;of the Code, and in applying Treas. Reg.
<FONT STYLE="white-space:nowrap">&#167;1.414(c)-2</FONT> for purposes of determining a controlled group of trades or businesses under Section&nbsp;414(c) of the Code, the language &#147;at least 50 percent&#148; shall be used instead of &#147;at
least 80 percent&#148; in each place it appears in Treas. Reg. <FONT STYLE="white-space:nowrap">&#167;1.414(c)-2.</FONT> Notwithstanding the foregoing, where justified by legitimate business criteria as determined by the Committee in its sole
discretion, &#147;at least 20 percent&#148; shall be substituted for &#147;at least 50 percent&#148; in the preceding sentence in determining whether a Participant has had a Termination of Service. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.02</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Award</B>&#148; means any Option, SAR, Restricted Stock Share, Restricted Stock Unit,
Performance Share, Performance Unit, Other Award or Stock granted as a bonus or in lieu of another award, together with any related right or interest, granted to an Eligible Person under the Plan. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.03</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Award Agreement</B>&#148; means the agreement setting forth the terms and conditions to which
an Award is subject, to the extent not provided in the Plan, together with any additional documents (such as Beneficiary designations) relating to a specific Award. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.04</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Beneficiary</B>&#148; means the individual or entity designated by the Participant to receive
the benefits specified under the Participant&#146;s Award upon such Participant&#146;s death. See Section&nbsp;10.03. No Beneficiary shall have any rights under the Plan prior to the death of the Participant. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.05</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Beneficial Owner</B>&#148; has the meaning specified in Rule
<FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.06</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Board</B>&#148; means the Board of Directors of the Company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.07</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Cause</B>&#148; shall be as defined in each Award Agreement, or if not so defined, means any
one or more of the following, as determined by the Committee or its delegate in its sole discretion: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Participant&#146;s commission of a felony or any crime of moral turpitude; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Participant&#146;s dishonesty or material violation of standards of integrity in the course of fulfilling his
or her employment duties to the Company or any Affiliate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a material violation of a material written policy of the Company or any Affiliate applicable to the
Participant, violation of which is grounds for immediate termination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">failure on the part of the Participant to perform his or her employment duties to the Company or any Affiliate
in any material respect, after reasonable notice of such failure and an opportunity to correct it; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">failure to comply in any material respect with any applicable legal or regulatory requirements, including but
not limited to the Foreign Corrupt Practices Act, the Securities Act of 1933, the Securities Exchange Act of 1934, the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, and the Truth in Negotiations
Act, or any rules or regulations thereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.08</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Change in Control</B>&#148; means any one or more of the following: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any one person, or more than one person acting as a group other than (A)&nbsp;an employee benefit plan (or
related trust) of the Company or a subsidiary or (B)&nbsp;the Company or a subsidiary (collectively, the &#147;Excluded Persons&#148;) acquires ownership of stock of the Company that, together with stock held by such person or group, constitutes
more than fifty percent (50%) of the total fair market value or total voting power of the stock of the Company; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any one person, or more than one person acting as a group (other than any Excluded Person), acquires (or has
acquired during the twelve (12)-month period ending on the date of the most recent acquisition by such person or persons) ownership of stock of the Company that constitutes thirty percent (30%) or more of the total fair market value or total voting
power of the stock of the Company; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any one person, or more than one person acting as a group (other than any Excluded Person), acquires (or has
acquired during the twelve (12)-month period ending on date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than forty percent (40%) of the total gross fair
market value of all the assets of the Company immediately before such acquisition or acquisitions; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a majority of members of the Board is replaced during any twelve (12)-month period by Directors whose
appointment or election is not endorsed by a majority of the members of the Board before the date of the appointment or election; provided, however, that no individual initially elected or nominated as a Director as a result of an actual or
threatened election contest with respect to directors or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than the Board shall be deemed to be a Director endorsed by a majority of the members
of the Board. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:11%; font-size:10pt; font-family:Times New Roman">Notwithstanding the provisions of this Section&nbsp;3.08, there shall not be a Change in Control if any
event described in Section&nbsp;3.08 occurs, and immediately following such event: (1)&nbsp;all or substantially all of the individuals and entities who are the Beneficial Owners, respectively, of the outstanding Stock and outstanding Company voting
securities immediately prior to such event will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:11%; font-size:10pt; font-family:Times New Roman">
beneficially own, directly or indirectly, more than fifty percent&nbsp;(50%) of, respectively, the outstanding shares of Stock, and the combined voting power of the then outstanding voting
securities entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from such event (including, without limitation, a corporation which as a result of such event owns the Company or all or
substantially all of the Company&#146;s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such corporate transaction, of the outstanding Stock and outstanding
Company voting securities, as the case may be; (2)&nbsp;no person (other than an Excluded Person or a corporation resulting from such event) will beneficially own, directly or indirectly, thirty percent (30%) or more of, respectively, the
outstanding shares of common stock of the corporation resulting from such event or the combined voting power of the outstanding voting securities of such corporation entitled to vote generally in the election of directors, except to the extent that
such ownership existed prior to the event; and (3)&nbsp;individuals who were members of the incumbent Board at the time of the Board&#146;s approval of the execution of the initial agreement providing for such corporate transaction will constitute
at least a majority of the members of the board of directors of the corporation resulting from such corporate transaction. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.09</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Code</B>&#148; means the Internal Revenue Code of 1986, as amended. Reference to any provision
of the Code or regulation thereunder shall include any successor provision and any regulations and other applicable guidance or pronouncement of the Internal Revenue Service or the Department of the Treasury and applicable case law relating to such
Section of the Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.10</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Committee</B>&#148; means the Compensation and Leadership Performance Committee of the Board,
the composition and governance of which is established in the Committee&#146;s charter as approved from time to time by the Board. Each member of the Committee is intended to qualify as &#147;independent&#148; as determined in accordance with the
regulations of the stock exchange on which the Stock is principally registered, and the Company&#146;s categorical standards, and to qualify as a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; under SEC Rule <FONT
STYLE="white-space:nowrap">16b-3.</FONT> However, no action of the Committee shall be void or deemed to be without authority due to the failure of any member, at the time the action was taken, to meet the foregoing qualification standards. The full
Board may perform any function of the Committee hereunder except to the extent limited under the applicable stock exchange policies and requirements for listed companies or the Company&#146;s bylaws, in which case the term &#147;Committee&#148;
shall refer to the Board. To the extent the Committee has delegated authority to another person or persons the term &#147;Committee&#148; shall refer to such other person or persons. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.11</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Company</B>&#148; means Walgreens Boots Alliance, Inc. and any successor thereto.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.12</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Deferred Award</B>&#148; means any Award to the extent that by its terms the Award will not or
might not be paid or otherwise settled in full no later than the 15th day of the third month after the later of (a)&nbsp;the last day of the first calendar year in which the Award is no longer subject to a Substantial Risk of Forfeiture or
(b)&nbsp;the last day of the Company&#146;s first fiscal year in which the Award is no longer subject to a Substantial Risk of Forfeiture. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.13</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Director</B>&#148; means a member of the Board. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.14</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Disability</B>&#148; means that the Participant has become disabled as provided in the
long-term disability plan of the Company or an Affiliate applicable to the Participant (or which would be applicable if the Participant was eligible for and elected coverage under such plan). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.15</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Dividend Equivalent</B>&#148; means a right granted to an Eligible Person to receive cash,
Stock, or other property equal in value to all or a specified portion of the dividends paid with respect to a specified number of shares of Stock in connection with dividend declarations, reclassifications, spin-offs, and the like.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.16</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Effective Date</B>&#148; is defined in the Preamble. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.17</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Eligible Person</B>&#148; means an employee of the Company or any Affiliate, or a <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.18</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934, as amended from time to time,
and the rules and regulations thereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.19</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Fair Market Value</B>&#148; means as of any applicable date: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Stock is listed on the NASDAQ Stock Market or other United States national securities exchange
registered under the Exchange Act, the value under such of the following as the Committee shall determine based on actual reported transactions in such Stock on the NASDAQ Stock Market or such other exchange: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The last sale before or the first sale after the date the Award is granted; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the closing sales price on such date or (whether or not sales are reported on such date) the last preceding
date on which a sale was reported; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the arithmetic mean of the high and low prices on such date or (whether or not sales are reported on such date)
the last preceding date on which sales were reported; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the average selling price of the Stock over a specified period beginning within 30 days before and ending
within 30 days after the applicable date, based on the arithmetic mean of such selling prices during the specified period, or an average of such prices weighted based on the volume of trading of the Stock on each trading date during the specified
period; provided, however, that such method may be used only if the relevant Eligible Person, the number and class of shares of Stock subject to such method, and the method for determining such price including the period over which the average are
determined, are irrevocably determined and set forth in an Award Agreement before the beginning of the specified period. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:11%; font-size:10pt; font-family:Times New Roman">The Committee may apply any of the foregoing methods for different purposes; provided, however, that if no other method is determined by the
Committee, the Fair Market Value shall be determined based on the closing sales price on the last preceding date on which a sale was reported, and the grant price for an Option or Stock Appreciation Right (other than an Option or Stock Appreciation
Right granted as a Substitute Award) shall be (i)&nbsp;the closing sales price on the date of grant if Stock is traded on such date, or (ii)&nbsp;the closing sales price on the next date on which Stock is traded. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If Stock is publicly traded but is not listed on any such exchange, any of the methods set forth in subsection
(a)&nbsp;applied to the bid quotations with respect to a share of Stock on the OTC Bulletin Board or other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> quotation system then in use as the principle
system then available for reporting or ascertaining quotations for the Stock; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If Stock is not publicly traded, the fair market value on the applicable date of a share of Stock as determined
by the Committee in good faith. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.20</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Former Plan</B>&#148; means the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as
amended. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.21</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>409A Compensation</B>&#148; means a Deferred Award or other compensation that is
&#147;nonqualified deferred compensation&#148; subject to Section&nbsp;409A of the Code, regardless of when granted or awarded. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.22</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Incentive Stock Option</B>&#148;<B> </B>or &#147;<B>ISO</B>&#148; means any Option intended to
qualify as an incentive stock option within the meaning of Section&nbsp;422 of the Code, and qualifying thereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.23</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director</B>&#148; means a Director who is
not an employee of the Company or an Affiliate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.24</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Nonstatutory Option</B>&#148; means an Option that is not an Incentive Stock Option.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.25</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Option</B>&#148; means a right granted to an Eligible Person to purchase a number of shares of
Stock (which may be Restricted Stock) at a specified price during a specified time period, and subject to such other terms and conditions as the Committee may determine. The term &#147;Option&#148; includes both an Incentive Stock Option and a
Nonstatutory Option. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.26</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Other Awards</B>&#148; means cash or stock-based awards granted to an Eligible Person under
Section&nbsp;7.08 or 7.09. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.27</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Participant</B>&#148; means an Eligible Person (or former Eligible Person) who has been granted
an Award under the Plan which remains outstanding or which remains subject to any provision of this Plan, including without limitation Sections 10.01 and 10.08. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.28</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Performance Award</B>&#148; means an Award that (in addition to any other conditions) is
conditional based upon the degree of satisfaction of performance criteria specified by the Committee. Performance Awards include, but are not limited to, Performance Shares and Performance Units. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.29</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Performance Share</B>&#148; means a conditional right granted to an Eligible Person to receive
a variable number of shares of Stock based upon the degree of satisfaction of performance criteria specified by the Committee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.30</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Performance Unit</B>&#148; means a conditional right granted to an Eligible Person to receive a
payment equal to the value of the performance unit based upon the degree of satisfaction of criteria specified by the Committee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.31</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Restricted Stock</B>&#148; means a Restricted Stock Share or a Restricted Stock Unit.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.32</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Restricted Stock Share</B>&#148; means a share of Stock granted to an Eligible Person under
Section&nbsp;7.03 which is subject to certain restrictions and to a substantial risk of forfeiture. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.33</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Restricted Stock Unit</B>&#148; or &#147;<B>RSU</B>&#148; means a bookkeeping entry
representing a hypothetical share of Stock granted to an Eligible Person under Section&nbsp;7.04 which is subject to certain restrictions and to a substantial risk of forfeiture. A Restricted Stock Unit shall have a nominal value on any date equal
to the Fair Market Value of one share of Stock on that date. A Restricted Stock Unit may be settled for cash, property, or shares of Stock, as specified in the Award Agreement, and may be a Performance Award. Restricted Stock Units represent an
unfunded an unsecured obligation of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.34</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Retire</B>&#148; or &#147;<B>Retirement</B>&#148; means a Termination of Service for any reason
other than a Termination of Service for Cause, Disability, or death after attaining age 55 and having at least 10 years of service (whether as an employee or Director) with the Company or any Affiliate. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.35</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></B>&#148; means Rule <FONT
STYLE="white-space:nowrap">16b-3,</FONT> as from time to time in effect and applicable to Participants, promulgated by the Securities and Exchange Commission under Section&nbsp;16 of the Exchange Act. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.36</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Separation from Service</B>&#148; means </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of an individual who is an employee of the Company or an Affiliate, the employee&#146;s termination
of employment with the Company and its Affiliates. Whether a termination of employment has occurred shall be determined based on whether the facts and circumstances indicate the individual and the employer reasonably anticipate that no further
services will be performed by the individual for the Company and its Affiliates; provided, however, that an individual shall be deemed to have a Separation from Service if the level of services he or she would perform for the Company and its
Affiliates after a certain date permanently decreases to no more than twenty percent (20%) of the average level of bona fide services performed for the Company and its Affiliates (whether as an employee or independent contractor) over the
immediately preceding <FONT STYLE="white-space:nowrap">36-month</FONT> period (or the full period of services to the Company and its Affiliates if the individual has been providing services for less than 36 months). For this purpose, an individual
is not treated as having a Separation from Service while he or she is on a military leave, sick leave, or other bona fide leave of absence, if the period of such leave does not exceed six months (90 days in the case of an Incentive Stock Option), or
if longer, so long as the individual has a right to reemployment with the Company or an Affiliate under an applicable statute or by contract; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of a Director, the individual ceases to be a Director of the Company and all Affiliates, unless
immediately upon such cessation the individual has a relationship with the Company or an Affiliate such that such cessation would not be a separation from service under Section&nbsp;409A of the Code, in which case a Separation from Service will
occur upon the cessation of such relationship as provided in Section&nbsp;409A of the Code; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of a consultant or advisor, the individual ceases to have a contractual obligation to perform
consulting services for the Company and all Affiliates, unless immediately upon such cessation the individual has a relationship with the Company or an Affiliate such that such cessation would not be a separation from service under Section&nbsp;409A
of the Code, in which case a Separation from Service will occur upon the cessation of such relationship as provided in Section&nbsp;409A of the Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding the foregoing, no such event shall be a Separation from Service if immediately upon such event
the individual continues to be an Eligible Person by reason of another relationship with the Company or any Affiliate from which no Separation from Service has occurred. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.37</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Specified Employee</B>&#148; means an individual who, as of the date of his or her Termination
of Service, is a key employee of the Company or any Affiliate whose stock is publicly traded, as determined under the policy of the Company as in effect from time to time, for determining &#147;specified employees&#148; consistent with the
requirements of Section&nbsp;409A of the Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.38</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Stock</B>&#148; means a share of the Company&#146;s common stock, $0.01 par value, and any
other equity securities of the Company that may be substituted or resubstituted for such Stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.39</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Stock Appreciation Right</B>&#148; or &#147;<B>SAR</B>&#148; means a right granted to an
Eligible Person to receive, upon exercise thereof, the excess of (A)&nbsp;the Fair Market Value of one share of Stock on the date of exercise over (B)&nbsp;the grant price of the SAR as determined by the Committee, which grant price shall be not
less than the Fair Market Value of a share of Stock on the date of grant of such SAR, except in the case of Substitute Awards. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.40</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Substantial Risk of Forfeiture</B>&#148; means such term as described in Treas.
Reg.&#167;&#167; <FONT STYLE="white-space:nowrap">1.409A-1(d)</FONT> and <FONT STYLE="white-space:nowrap">1.409A-1(b)(4).</FONT> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.41</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Termination of Service</B>&#148; &#147;<B>termination of employment</B>&#148;, and words of
similar import, unless the context clearly indicates otherwise, mean termination of employment (or for a Participant who is not an employee, termination of service), as determined by the Committee; provided that in the case of an Award that is 409A
Compensation, such term shall mean Separation from Service. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>IV.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Administration </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>4.01</B>&#8195;<B>&#8194;&#8199;Authority of the Committee</B>. The Plan shall be administered by the Committee or by a duly appointed
delegate of the Committee, which shall have full and final authority, in its discretion, in each case subject to and consistent with the provisions of the Plan, </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to determine which Eligible Persons shall be granted Awards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to determine the type and size of Awards, the dates on which Awards may be granted, exercised or settled and on
which the risk of forfeiture or any deferral period relating to Awards shall lapse or terminate, and to accelerate any such dates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to determine the expiration date of any Award; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to determine whether an Award will be granted on a standalone or tandem basis; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to determine whether, to what extent, and under what circumstances an Award may be settled, or the exercise
price of an Award may be paid, in cash, Stock, other Awards, or other property; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to determine other terms and conditions of, and all other matters relating to, Awards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to prescribe Award Agreements evidencing or setting terms of Awards (such Award Agreements need not be
identical for each Participant); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to adopt amendments to Award Agreements; provided that, except as set forth herein or in the Award Agreement,
the Committee shall not amend an Award Agreement in a manner that materially and adversely affects the Participant without the consent of the Participant (for this purpose, actions that alter the timing of federal income taxation of a Participant
will not be deemed material unless such action results in an income tax penalty on the Participant); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to establish rules and regulations for the administration of the Plan and amendments thereto and to create <FONT
STYLE="white-space:nowrap">sub-plans;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to determine whether, to what extent, and under what circumstances any Award shall be terminated or forfeited
or the Participant shall be required to disgorge to the Company gains or earnings attributable to an Award; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to construe and interpret the Plan and Award Agreements and correct defects, supply omissions or reconcile
inconsistencies therein; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to make all other decisions and determinations (including factual determinations) in its discretion as the
Committee may deem necessary or advisable for the administration of the Plan. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Decisions of the Committee with respect to the
administration and interpretation of the Plan and any Award Agreement shall be final, conclusive, and binding upon all persons interested in the Plan, including all Eligible Persons, Participants, Beneficiaries, transferees under
Section&nbsp;6.05(c) and other persons claiming rights from or through a Participant, and stockholders. The foregoing notwithstanding, to the extent required by the Company&#146;s bylaws, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Board shall perform the functions of the Committee for purposes of granting Awards under the Plan to <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors and shall have all the powers
of the Committee with respect thereto (authority with respect to other aspects of <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director awards is not exclusive to the Board, however). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>4.02</B>&#8195;<B>&#8194;&#8199;Manner of Exercise of Committee Authority</B>. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Committee may act through subcommittees, including for purposes of perfecting exemptions under Rule <FONT
STYLE="white-space:nowrap">16b-3</FONT> (in which case the members of the Committee who qualify as <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors shall act as the Committee). The express grant of any specific power to the Committee,
and the taking of any action by the Committee or a subcommittee, shall not be construed as limiting any power or authority of the Committee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the Company&#146;s bylaws and applicable law, the Committee may delegate to any other committee of
the Board or to one or more members of the Board the authority, subject to such terms as the Committee may determine, to exercise such powers and authority and perform such functions as the Committee in its discretion may determine. Such delegation
may be revoked at any time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Committee may delegate to officers of the Company or any Affiliate, or committees thereof, the authority,
subject to such terms as the Committee shall determine, to perform such functions and exercise such powers and authority, as the Committee in its discretion may determine, to the fullest extent permitted under the Delaware General Corporation Law
and the Company&#146;s bylaws. Such delegation may be revoked at any time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Except to the extent prohibited by applicable law, the Committee may delegate to one or more individuals the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> administration of the Plan and any of the functions assigned to the Committee under the Plan. Such delegation may be revoked at any time. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>4.03</B>&#8195;<B>&#8194;&#8199;Advisors and Agents of the Committee</B>. The Committee may (i)&nbsp;authorize one or more of its members
or an agent to execute or deliver any instrument, and make any payment on its behalf and (ii)&nbsp;utilize and cause the Company to pay for the services of associates and engage accountants, agents, clerks, legal counsel, record keepers and
professional consultants (any of whom may also be serving another Affiliate of the Company) to assist in the administration of this Plan or to render advice with regard to any responsibility under this Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>4.04</B>&#8195;<B>&#8194;&#8199;Records and Reports of the Committee</B>. The Committee shall maintain records and accounts relating to the
administration of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>4.05</B>&#8195;<B>&#8194;&#8199;Limitation of Liability; Indemnification</B>. The members of the Board,
the Committee, and their delegates, shall have no liability with respect to any action or omission made by them in good faith nor from any action made in reliance on (i)&nbsp;the advice or opinion of any accountant, legal counsel, medical adviser or
other professional consultant or (ii)&nbsp;any resolutions of the Board certified by the secretary or assistant secretary of the Company. Each member of the Board, the Committee, and each employee of the Company or any Affiliate to whom are
delegated duties, responsibilities and authority with respect to the Plan shall be indemnified, defended, and held harmless by the Company and its Affiliates and their respective successors against all claims, liabilities, fines and penalties and
all expenses (including but not limited to attorneys&#146; fees) reasonably incurred by or imposed on such member or employee that arise as a result of his actions or failure to act in connection with the operation and administration of the Plan, to
the extent lawfully allowable and to the extent that such claim, liability, fine, penalty or expense is not paid for by liability insurance purchased by or paid for by the Company or an Affiliate. Notwithstanding the foregoing, the Company or an
Affiliate shall not indemnify any person for any such amount incurred through any settlement or compromise of any action unless the Company or Affiliate consents in writing to such settlement or compromise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>4.06</B>&#8195;<B>&#8194;&#8199;Expenses</B>. Expenses relating to the Plan prior to its termination shall be paid from the general assets
of the Company or an Affiliate. Any individual who serves<I> </I>as a member of the Committee shall receive no additional compensation for such service. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>4.07</B>&#8195;<B>&#8194;&#8199;Service in More than One Capacity</B>. Any person or
group of persons may serve<I> </I>the Plan in more than one capacity. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>V.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Shares Subject to Plan </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>5.01</B>&#8195;<B>&#8194;&#8199;Overall Number of Shares Available for Delivery</B>. Subject to adjustment as provided in Section&nbsp;5.04,
the total number of shares of Stock reserved and available for delivery in connection with Awards under the Plan shall be: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares of Stock available as of the Effective Date under the Former Plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares of Stock which have become available from the Former Plan after the Effective Date in accordance with
Section&nbsp;5.02; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">65&nbsp;million additional shares of Stock, which became available as of the Effective Date, as approved by
stockholders of the Company at the Company&#146;s 2021 annual meeting of stockholders; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">61.5&nbsp;million additional shares of Stock, as approved by stockholders of the Company at the Company&#146;s
2025 annual meeting of stockholders and which became available as of the A&amp;R Effective Date; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, however, that the total
number of shares with respect to which ISOs may be granted shall not exceed 61,500,000. Of the shares described in (a), (b), (c) and (d), 100% may be delivered in connection with &#147;full-value Awards,&#148; meaning Awards other than Options,
SARs, or Awards for which the Participant pays for the shares of Stock subject to the Award either directly or in exchange for (or by foregoing) a right to receive a cash payment from the Company equal to the fair market value of the Award;
provided, however, that any shares granted under Options or SARs shall be counted against the share limit on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis and any shares granted as full-value
Awards shall be counted against the share limit as three&nbsp;(3) shares for every one&nbsp;(1) share subject to such Award. The Company shall at all times during the term of the Plan retain as authorized and unissued Stock or treasury Stock at
least the number of shares of Stock from time to time required under the provisions of the Plan, or otherwise assure itself of its ability to perform its obligations hereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>5.02</B>&#8195;<B>&#8194;&#8199;Share Counting Rules</B>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Committee may adopt reasonable counting procedures to ensure appropriate counting, avoid double counting
(as, for example, in the case of tandem or substitute awards) and make adjustments if the number of shares of Stock actually delivered differs from the number of shares previously counted in connection with an Award. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares of Stock subject to an Award will again be available for Awards if the Award (or an award under the
Former Plan) is canceled, expired, forfeited, settled in cash or otherwise terminated or settled without delivery of the full number of shares of Stock subject to such Award. The following shares of Stock will not be added to the total number of
shares available or to be made available again for delivery under the Plan: (i)&nbsp;shares not issued or not delivered as a result of the net settlement of an outstanding Option or Stock Appreciation Right; (ii)&nbsp;shares delivered to or withheld
by the Company to pay the exercise price of or withholding taxes with respect to an Award; and (iii)&nbsp;shares of Stock repurchased by the Company on the open market with the proceeds from the payment of the exercise price of an Option.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of any Award granted in substitution for an award of a company or business acquired by the Company
or an Affiliate (a &#147;Substitute Award&#148;), shares delivered or to be delivered in connection with such Substitute Award shall not be counted against the number of shares reserved under the Plan, but shall be available under the Plan by virtue
of the Company&#146;s assumption of the plan or arrangement of the acquired company or business. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Section shall apply to the number of shares reserved and available for ISOs only to the extent consistent
with applicable regulations relating to ISOs under the Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Because shares will count against the number reserved in Section&nbsp;5.01 upon delivery (or later vesting) and
subject to the share counting rules under this Section&nbsp;5.02, the Committee may determine that Awards may be outstanding that relate to more shares than the aggregate remaining available under the Plan, so long as Awards will not result in
delivery and vesting of shares in excess of the number then available under the Plan. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>5.03</B>&#8195;<B>&#8194;&#8199;Director Award Limits</B>. The aggregate value of cash compensation and the grant date fair value of shares
of Stock that may be paid or granted during any fiscal year of the Company to any <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director shall not exceed $750,000; provided, however, that this limit shall not apply to distributions of
previously deferred compensation under a deferred compensation plan maintained by the Company or an Affiliate or compensation received by the Director in his or her capacity as an executive officer or employee of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>5.04</B>&#8195;<B>&#8194;&#8199;Adjustments</B>. In the event that any large, special and
<FONT STYLE="white-space:nowrap">non-recurring</FONT> dividend or other distribution (whether in the form of cash or property other than Stock), recapitalization, forward or reverse split, stock dividend, reorganization, merger, consolidation, <FONT
STYLE="white-space:nowrap">spin-off,</FONT> combination, repurchase, share exchange, liquidation, dissolution or other similar corporate transaction or event affects the shares of Stock such that an adjustment is appropriate, or, in the case of any
outstanding Award, necessary, in order to prevent dilution or enlargement of the rights of the Participant, then the Committee shall, in an equitable manner as determined by the Committee, adjust any or all of (i)&nbsp;the aggregate number and kind
of shares of Stock which may be delivered in connection with Awards granted under the Plan, (ii)&nbsp;the number and kind of shares of Stock subject to or deliverable in respect of outstanding Awards, and (iii)&nbsp;the exercise price, grant price
or purchase price relating to any Award or, if deemed appropriate, the Committee may make provision for a payment of cash or property to the holder of an outstanding Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>5.05</B>&#8195;<B>&#8194;&#8199;Former Plan</B>. Upon the Effective Date, no further grants of Awards will be made under the Former Plan.
</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>VI.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Eligibility and General Conditions for Awards </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>6.01</B>&#8195;<B>&#8194;&#8199;Eligibility</B>. Awards may be granted under the Plan only to Eligible Persons. The Committee shall
determine, in its sole discretion, the extent to which a Participant shall be considered employed during an approved leave of absence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>6.02</B>&#8195;<B>&#8194;&#8199;Awards</B>. Awards may be granted on the terms and conditions set forth in this Plan. In addition, the
Committee may impose on any Award, or the exercise thereof, at the date of grant (subject to Section&nbsp;10.06), such additional terms and conditions, not inconsistent with the provisions of the Plan, as the Committee shall determine in its sole
discretion, including performance conditions for the exercise or vesting of an Award, terms requiring forfeiture of Awards in the event of Termination of Service by the Participant or other events or actions by the Participant, terms for deferred
payment or other settlement of an Award, and terms permitting a Participant to make elections relating to his or her Award. Such terms and conditions need not be uniform among types of Awards nor among Eligible Persons receiving the same type of
Award. The Committee shall retain full power and discretion with respect to any term or condition of an Award that is not mandatory under the Plan. The Committee shall require the payment of lawful consideration for an Award to the extent necessary
to satisfy the requirements of the Delaware General Corporation Law, and may otherwise require payment of consideration for an Award except as limited by the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>6.03</B>&#8195;<B>&#8194;&#8199;Award Agreement</B>. To the extent not set forth in the Plan, the terms and conditions of each Award shall
be set forth in an Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>6.04</B>&#8195;<B>&#8194;&#8199;Vesting; Termination of Service</B>. The Committee may determine
and set forth in the Award Agreement the vesting schedule for the Award and the extent to which an Award not vested shall be forfeited or shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
terminate upon a Participant&#146;s Termination of Service. No portion of an Award shall become exercisable or vested prior to the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of
the date of grant; provided, that the following awards shall not be subject to the foregoing minimum vesting requirement: any (i)&nbsp;Substitute Awards granted in connection with awards that are assumed, converted or substituted pursuant to a
merger, acquisition or similar transaction entered into by the Company or any of its Subsidiaries, (ii)&nbsp;shares of Common Stock delivered in lieu of fully vested cash obligations, (iii)&nbsp;Awards to
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors that vest on earlier of the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after
the immediately preceding year&#146;s annual meeting, and (iv)&nbsp;any additional Awards the Committee may grant, up to a maximum of five percent&nbsp;(5%) of the available share reserve authorized for issuance under the Plan (subject to adjustment
under Section&nbsp;5.04). This Section&nbsp;6.04 shall not restrict the right of the Committee to accelerate or continue the vesting or exercisability of an Award upon or after a Change in Control or termination of employment or otherwise pursuant
to Section&nbsp;4.01 or 6.04(d) of the Plan. Subject to the below subsections, Awards held by a Participant upon Termination of Service shall be treated as set forth in the applicable Award Agreement, based on the determination by the Committee in
its sole discretion of the reason for Termination of Service: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Cause. </I>Upon a Participant&#146;s Termination of Service for Cause, all Awards (whether or not then
vested or forfeitable under the terms of the Award) shall be forfeited and terminate. In the event that within one year after Termination of Service a Participant commits an act or omission that would be Cause, or it is discovered that the
Participant has committed such act or omission before Termination of Service, then the Committee may in its discretion determine that the Termination of Service shall be deemed to have occurred for Cause. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Automatic Extended Exercisability in Certain Cases. </I>Notwithstanding the foregoing provisions of this
Section or the applicable Award Agreement, if the date a vested Award would otherwise terminate is a date that the Participant is prohibited from exercising the Award under the Company&#146;s insider trading policy or such other conditions under
applicable securities laws as the Committee shall specify, the term of the Award, to the extent vested, shall be extended to the second business day after the Participant is no longer so prohibited from exercising the Award, but in no event shall
the Award be extended beyond the original stated term of the Award. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Automatic Exercise in Certain Cases. </I>In addition, if determined by the Committee in its discretion, on
such terms and conditions and under such circumstances as the Committee shall establish, which may be applied differently among Participants or Awards, Options and SARs will be deemed exercised by the Participant (or in the event of the death of or
authorized transfer by the Participant by the beneficiary or transferee) on the expiration date of the Option or SAR using a net share settlement (or net settlement) method of exercise to the extent that as of such expiration date the Option or SAR
is vested and exercisable and the per share exercise price of the Option or SAR is below the Fair Market Value of a share of Stock on such expiration date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Waiver by Committee. </I>Notwithstanding the foregoing provisions of this Section, the Committee may in its
sole discretion as to all or part of any Award as to any Participant, at the time the Award is granted or thereafter, which treatment need not be uniform among Participants, determine that Awards shall become exercisable or vested upon a Termination
of Service, determine that Awards shall continue to become exercisable or vested in full or in installments after Termination of Service, extend the period for exercise of Options or SARs following Termination of Service (but not beyond the original
stated term of the Option or SAR), or provide that any performance-based Award shall in whole or in part not be forfeited upon such Termination of Service. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>6.05</B>&#8195;<B>&#8194;&#8199;Nontransferability of Awards</B>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">During the Participant&#146;s lifetime, each Award and each right under any Award shall be exercisable only by
the Participant or, if permissible under applicable law, by the Participant&#146;s guardian or legal representative, or by a transferee receiving such Award </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
pursuant to a domestic relations order issued by a court with jurisdiction over the Company, requiring the transfer of the Award. Nothing herein shall be construed as requiring the Committee to
honor a domestic relations order except to the extent required under applicable law. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No Award (prior to the time, if applicable, unrestricted shares of Stock are delivered in respect of such Award
or Restricted Stock Shares becomes unrestricted), and no right under any Award, may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by a Participant otherwise than by will or by the laws of descent and
distribution (or in the case of Restricted Stock Shares, by transfer to the Company); and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or any
Affiliate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding subsections (a)&nbsp;and (b) above, a Participant may transfer a Nonstatutory Option or SAR for
no consideration to a Permitted Transferee in accordance with rules and subject to such conditions as may be specified by the Committee in the Award Agreement or in the Committee&#146;s rules or procedures of general application. For this purpose, a
&#147;Permitted Transferee&#148; in respect of any Participant means any member of the Immediate Family of such Participant, any trust of which all of the primary beneficiaries are such Participant or members of his or her Immediate Family, or any
partnership (including limited liability companies and similar entities) of which all of the partners or members are such Participant or members of his or her Immediate Family; and the &#147;Immediate Family&#148; of a Participant includes any
child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mother-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">father-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">son-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">daughter-in-law,</FONT></FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">brother-in-law,</FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">sister-in-law,</FONT></FONT> including adoptive relationships, any person sharing the
employee&#146;s household (other than a tenant or employee), a trust in which these persons have more than fifty percent of the beneficial interest, a foundation in which these persons (or the employee) control the management of assets, and any
other entity in which these persons (or the employee) own more than fifty percent of the voting interests. Such Award may be exercised by such transferee in accordance with the terms of such Award. Following the transfer of a Nonstatutory Stock
Option or SAR to a Permitted Transferee, the Permitted Transferee shall have all of the rights and obligations of the Participant to whom the Award was granted and such Participant shall not retain any rights with respect to the transferred Award,
except that (i)&nbsp;the payment of any tax attributable to the exercise of the Nonstatutory Option or SAR shall remain the obligation of the Participant, and (ii)&nbsp;the period during which the Nonstatutory Option or SAR shall become exercisable
or remain exercisable shall depend on the service of the original Participant and the circumstances of his or her Termination of Service. A Permitted Transferee may not again transfer an Award to another Permitted Transferee. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If for any reason an Award is exercised or shares of Stock are to be delivered or payment is to be made under
any Award to a person other than the original Participant, the person exercising or receiving delivery or payment under such Award shall, as a condition to such exercise, delivery or receipt, supply to the Committee such evidence as the Committee
may reasonably require to establish the identity of such person and such person&#146;s right to exercise or receive delivery or payment under such Award. A Permitted Transferee or other transferee, Beneficiary, guardian, legal representative or
other person claiming any rights under the Plan from or through any Participant shall be subject to the provisions of the Plan and any applicable Award Agreement, except to the extent the Plan and Award Agreement otherwise provide with respect to
such persons, and to any additional restrictions or limitations deemed necessary or appropriate by the Committee. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>6.06</B>&#8195;<B>&#8194;&#8199;Cancellation and Rescission of Awards</B>. Unless the Award Agreement specifies otherwise, the Committee
may cancel, rescind, suspend, withhold, or otherwise limit or restrict any unexercised Award at any time if the Participant is not in compliance with all applicable provisions of the Award Agreement and the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>6.07</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Stand-Alone, Tandem and Substitute Awards. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Awards granted under the Plan may, in the discretion of the Committee, be granted either alone or in addition
to, in tandem with, or in substitution for, any other Award granted under the Plan. If an Award is granted in substitution for another Award or any <FONT STYLE="white-space:nowrap">non-Plan</FONT> award or benefit, the Committee shall require the
surrender of such other Award or <FONT STYLE="white-space:nowrap">non-Plan</FONT> award or benefit in consideration for the grant of the new Award. Awards granted in addition to or in tandem with other Awards or
<FONT STYLE="white-space:nowrap">non-Plan</FONT> awards or benefits may be granted either at the same time as or at a different time from the grant of such other Awards or <FONT STYLE="white-space:nowrap">non-Plan</FONT> awards or benefits.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Committee may, in its discretion and on such terms and conditions as the Committee considers in the
circumstances, grant Substitute Awards under the Plan in substitution for stock and stock-based awards (&#147;Acquired Entity Awards&#148;) held immediately prior to a merger, consolidation or acquisition by employees or directors of another
corporation or entity who become Eligible Persons as the result of a merger or consolidation of the employing corporation or other entity (the &#147;Acquired Entity&#148;) with the Company or an Affiliate or the acquisition by the Company or an
Affiliate of property or stock of the Acquired Entity, in order to preserve for such newly Eligible Persons the economic value of all or a portion of such Acquired Entity Award, at such price as the Committee determines necessary to achieve
preservation of economic value, subject to Section&nbsp;409A of the Code. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>6.08</B><B>&#8195;&#8194;&#8196;Deferred
Awards</B>. The Committee may provide in an Award Agreement that the Award shall be in whole or in part a Deferred Award. In addition, the Committee may provide, in a manner specified by the Committee in the Award Agreement or in the
Committee&#146;s rules and procedures of general application, that a Participant may elect to defer settlement of an Award so that the Award becomes a Deferred Award, subject to the following terms and to such additional terms and conditions as the
Committee shall designate in its discretion: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Deferral Elections. </I>An election to defer an Award shall be made on or before December&nbsp;31 of the
calendar year preceding the calendar year in which the Award is granted, on a form (which may be electronic) authorized by the Committee, and except as provided in Section&nbsp;7.07 shall not carry over from year to year unless the Committee timely
provides otherwise. Such election shall become irrevocable for the period to which it applies as of the last date for making such election. The deferral election shall include (i)&nbsp;the designation and portion of the Award to be deferred,
(ii)&nbsp;the date on which settlement of the deferred Award shall be made or commence (which may be a fixed date such as the Participant&#146;s attainment of a particular age, the Participant&#146;s Termination of Service for any reason, or such
other dates or circumstances as may be required or permitted by the Committee); and (iii)&nbsp;whether settlement shall be made on a single date or in installments over a period and subject to such terms and conditions as may be set by the Committee
at the time of the deferral election. If there is no election as to form of settlement, then settlement shall be made no later than 90 days following the date designated in (ii), in a lump sum in cash, shares of Stock, or such other medium as the
Committee may designate, as specified in the Award Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>New Participants. </I>Notwithstanding subsection (a)&nbsp;above, the Committee may permit a deferral
election to be made by a Participant who was never previously eligible to defer an Award and was never previously eligible to defer compensation under any other plan required by Section&nbsp;409A of the Code to be aggregated with deferrals of Awards
under this Plan. Such an individual&#146;s deferral election shall be made within 30 days of becoming newly eligible to defer an Award and shall be effective only with respect to a fractional portion of the Award determined by multiplying
(separately with respect to each applicable vesting date), the grant date value of the number of applicable portion of shares of Stock (or other portion of an Award not denominated in shares of Stock) vesting on such vesting date by a fraction, the
numerator of which is the number of calendar days between the date </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
the deferral election is received by the Committee and the date such Award (or portion thereof) vests, and the denominator of which is the total number of calendar days between the grant date and
the vesting date. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Performance-Based Compensation. </I>Notwithstanding subsection (a)&nbsp;above, the Committee may permit a
deferral election to be made by a Participant with respect to a Performance Award on or before a date that is at least six months before the end of the applicable performance period of at least 12 months, provided the Participant has continuously
performed services from the later of the beginning of the performance period or the date the performance criteria are established (provided they are established within 90 days of the beginning of the performance period) through the date such
election is made, and provided that the compensation to be paid under the Performance Award is not at the time of the election readily ascertainable within the meaning of Treas. Reg. &#167; <FONT STYLE="white-space:nowrap">1.409A-2(a)(8).</FONT>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Awards Vesting in More than Twelve Months. </I>Notwithstanding subsection (a)&nbsp;above, the Committee may
permit a deferral election to be made by a Participant with respect to an Award that is subject to a condition requiring the Participant to continue to remain employed for a period of at least 12 months from the date of the grant. Such a deferral
election, if permitted, must be made on or before the 30th day after the grant date, provided that the election is made at least 12 months in advance of the earliest vesting date (other than vesting on account of death or a Change in Control).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Dividend Equivalents on Deferred Awards. </I>To the extent specified in the Award Agreement, Dividend
Equivalents may be credited to deferred Awards (other than Options and SARs) during the deferral period, subject to such terms and conditions as the Committee shall specify. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>6.09</B><B>&#8195;&#8194;&#8196;Additional and Substitute Awards</B>. Subject to Section&nbsp;10.07, Awards granted under the Plan may, in
the discretion of the Committee, be granted either in addition to, or in substitution or exchange for, any other Award or any award granted under another plan of the Company, any Affiliate, or any business entity acquired or to be acquired by the
Company or an Affiliate. An Award may specify that the Participant is to receive payment from the Company or any Affiliate. Awards granted in addition to other Awards or awards may be granted either as of the same time as or a different time from
the grant of such other Awards or awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>6.10</B><B>&#8195;&#8194;&#8196;Interest</B>. Unless interest is specifically provided for
in this Plan or the Award Agreement, no interest will be paid on Awards. The Award Agreement may include, without limitation, provisions for the payment or crediting of reasonable interest on installment or deferred payments or the granting or
crediting of Dividend Equivalents or other amounts in respect of installment or deferred payments denominated in Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>6.11</B><B>&#8195;&#8194;&#8196;Exemptions from Section</B><B></B><B>&nbsp;16(b) Liability</B>. With respect to a Participant who is then
subject to the reporting requirements of Section&nbsp;16(a) of the Exchange Act in respect of the Company, the Committee shall grant Awards under the Plan and otherwise administer the Plan in a manner so that the grant and exercise of each Award
with respect to such a Participant may qualify for an available exemption from liability under Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> Rule <FONT STYLE="white-space:nowrap">16b-6,</FONT> or otherwise not be subject to liability under
Section&nbsp;16(b), provided that this provision shall not be construed to limit sales or other dispositions by such a Participant (in connection with an exercise or otherwise), and shall not limit a Participant&#146;s ability to engage in other <FONT
STYLE="white-space:nowrap">non-exempt</FONT> transactions under the Plan. The Committee may authorize the Company to repurchase any Award or shares of Stock deliverable or delivered in connection with any Award in order to avoid a Participant who is
subject to Section&nbsp;16 of the Exchange Act incurring liability under Section&nbsp;16(b). Unless otherwise specified by the Participant, equity securities or derivative securities acquired under the Plan which are disposed of by a Participant
shall be deemed to be disposed of in the order acquired by the Participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>VII.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Specific Provisions for Awards </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>7.01</B><B>&#8195;&#8194;&#8196;Options</B>. The Committee is authorized to grant Options to Eligible Persons on the following terms and
conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Exercise Price. </I>The exercise price per share of Stock purchasable under an Option (including both ISOs
and Nonstatutory Options) shall be determined by the Committee, provided that, except with respect to Substitute Awards, such exercise price shall be not less than the Fair Market Value of a share of Stock on the date of grant of such Option.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Option Term; Time and Method of Exercise. </I>The Committee shall determine the term of each Option, which
in no event shall exceed a period of ten years from the date of grant. The Committee shall determine the time or times at which or the circumstances under which an Option may be exercised in whole or in part (including based on achievement of
performance goals and/or future service requirements), the methods by which such exercise price may be paid or deemed to be paid and the form of such payment, including, without limitation, cash, Stock (including Stock deliverable upon exercise),
Restricted Stock or other property that does not have a deferral feature, other Awards or awards granted under other plans of the Company or any Affiliate, or other property (including through &#147;net exercise&#148; or &#147;cashless
exercise&#148; arrangements, to the extent permitted by applicable law), and the methods by or forms in which Stock will be delivered or deemed to be delivered in satisfaction of Options. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Incentive Stock Options</I>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Only employees (as determined in accordance with Section&nbsp;3401(c) of the Code) of the Company or any of its
subsidiaries may be granted Incentive Stock Options. For this purpose, &#147;subsidiary&#148; means any company (other than the Company) in an unbroken chain beginning with the Company; provided each company in the unbroken chain (other than the
Company) owns, at the time of determination, stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other companies in such chain. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If and to the extent that the aggregate Fair Market Value of the Stock (determined as of the date of grant)
with respect to which a Participant&#146;s Incentive Stock Options are exercisable for the first time during any calendar year exceeds $100,000, such Options shall be treated as Nonstatutory Options. For purposes of applying this limitation,
Incentive Stock Options shall be taken into account in the order in which they were granted. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No Incentive Stock Option shall be granted more than ten years after the earlier of the adoption of the Plan or
stockholder approval of the Plan; provided that after the initial adoption of the Plan, such <FONT STYLE="white-space:nowrap">ten-year</FONT> period shall be measured from the earlier of Board adoption of a subsequent amendment of the Plan requiring
stockholder approval or stockholder approval of the Plan as so subsequently amended. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Award Agreements evidencing Incentive Stock Options shall contain such other terms and conditions as may be
necessary to comply with the applicable provisions of Section&nbsp;422 of the Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Dividend Equivalents. </I>No dividends or Dividend Equivalents shall be payable, credited or accrued with
respect to an Option. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>7.02</B><B>&#8195;&#8194;&#8196;Stock Appreciation Rights</B>. The Committee is
authorized to grant SARs to Eligible Persons. The Committee shall determine the term of each SAR, provided that in no event shall the term of an SAR exceed a period of ten years from the date of grant. The Committee shall determine at the date of
grant the time or times at which and the circumstances under which an SAR may be exercised in whole or in part (including based on achievement of performance goals and/or future service requirements), the method of exercise, method of settlement,
form of consideration payable in settlement (whether cash, Stock, or other property), and the method by or forms in which Stock will be delivered or deemed to be delivered to Participants, whether or not an SAR shall be free-standing or in tandem or
combination with any other Award. The base price per share of Stock subject to an SAR shall be determined by the Committee, provided that, except with respect to Substitute Awards, such base price shall be not less than the Fair Market Value of a
share of Stock on the date of grant of such SAR. No dividends or Dividend Equivalents shall be payable, credited or accrued with respect to an SAR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>7.03</B><B>&#8195;&#8194;&#8196;Restricted Stock Shares</B>. The Committee is authorized to grant Restricted Stock Shares to Eligible
Persons on the following terms and conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Grant and Restrictions. </I>Restricted Stock Shares shall be subject to such restrictions on
transferability, risk of forfeiture and other restrictions, if any, as the Committee may impose, which restrictions may lapse separately or in combination at such times, under such circumstances (including based on achievement of performance goals
and/or future service requirements), in such installments or otherwise and under such other circumstances as the Committee may determine at the date of grant or thereafter. A Participant shall pay such consideration for the Restricted Stock Shares
as the Committee may require, which shall not be less than the par value of the Restricted Stock Shares on the date of grant unless the Restricted Stock Shares are to be settled in treasury shares. Section&nbsp;10.04(b) (restricting elections under
Section&nbsp;83(b)of the Code) shall apply to Restricted Stock Shares except to the extent provided in the Award Agreement. Except to the extent restricted under the terms of the Plan or any Award Agreement relating to the Restricted Stock Shares, a
Participant granted Restricted Stock Shares shall have all of the rights of a stockholder, including the right to vote the Restricted Stock Shares and the right to receive dividends thereon (subject to subsection (c)&nbsp;below).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Evidence of Stock Ownership. </I>Restricted Stock Shares granted under the Plan may be evidenced in such
manner as the Committee shall determine, including appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company. If certificates representing Restricted Stock Shares are registered in the name of the
Participant, the Committee may require that such certificates bear an appropriate legend referring to the terms, conditions and restrictions applicable to such Restricted Stock Shares, that the Company retain physical possession of the certificates,
and that the Participant deliver a stock power to the Company, endorsed in blank, relating to the Restricted Stock Shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Dividends and Splits. </I>Any cash dividends paid on a Restricted Stock Share shall be automatically
reinvested in additional Restricted Stock Shares or held in kind, which shall be subject to the same terms as applied to the original Restricted Stock to which it relates. Cash, shares of Stock or other property distributed in connection with a
stock split or stock dividend, and other property distributed as a <FONT STYLE="white-space:nowrap">non-cash</FONT> dividend, shall be subject to restrictions and a risk of forfeiture to the same extent as the Restricted Stock Shares with respect to
which such Stock or other property has been distributed. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>7.04</B>&#8195;&#8194;&#8196;<B>Restricted Stock Units</B>.
The Committee is authorized to grant RSUs to Eligible Persons, subject to the following terms and conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Award and Restrictions. </I>RSUs shall be subject to restrictions constituting a Substantial Risk of
Forfeiture, which conditions may be time-based or performance-based. Unless deferred pursuant to Section&nbsp;6.08, settlement of RSUs by delivery of cash, shares of Stock, or other property, as specified in the Award Agreement, shall occur upon the
lapse of the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Substantial Risk of Forfeiture, but no later than the 15th day of the third month after the later of (a)&nbsp;the last day of the first calendar year in which the Award is no longer subject to a
Substantial Risk of Forfeiture or (b)&nbsp;the last day of the Company&#146;s first fiscal year in which the Award is no longer subject to a Substantial Risk of Forfeiture. In addition, RSUs shall be subject to such restrictions on transferability
and other restrictions, if any, as the Committee may impose, which restrictions may lapse at the same time as the Substantial Risk of Forfeiture or at earlier or later specified times, separately or in combination, in installments or otherwise, and
under such other circumstances as the Committee may determine at the date of grant or thereafter. Except as restricted under the terms of the Plan or any Award Agreement relating to the RSUs, prior to settlement a Participant granted RSUs shall have
the right to receive Dividend Equivalents thereon pursuant to subsection (b)&nbsp;but shall have no right to vote respecting the RSUs or any other rights of a stockholder. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Dividend Equivalents. </I>Unless otherwise determined by the Committee, Dividend Equivalents on RSUs shall
be automatically deemed reinvested in RSUs and shall be paid when the RSUs to which they relate are settled. Notwithstanding the foregoing, Dividend Equivalents shall be forfeited if the RSUs to which they relate are forfeited or otherwise not
earned. Cash, shares of Stock or other property distributed in connection with a stock split or stock dividend, and other property distributed as a dividend, shall be subject to restrictions and Substantial Risk of Forfeiture to the same extent as
the RSUs with respect to which such Stock or other property has been distributed. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>7.05</B>&#8195;&#8194;&#8196;<B>Dividend Equivalents</B>. The Committee is authorized to grant Dividend Equivalents to an Eligible Person,
entitling the Participant to receive cash, shares of Stock, other Awards, or other property equivalent to all or a portion of the dividends paid with respect to a specified number of shares of Stock. Dividend Equivalents may be awarded on a
freestanding basis or in connection with another Award. The Committee may provide that Dividend Equivalents shall be paid or distributed when accrued or shall be deemed to have been reinvested in additional Stock, Awards, or other investment
vehicles, and subject to restrictions on transferability, risks of forfeiture and such other terms as the Committee may specify with due regard to the applicability of Section&nbsp;409A of the Code. Notwithstanding the foregoing, (a)&nbsp;Dividend
Equivalents shall not be provided with respect to Options or Stock Appreciation Rights, and (b)&nbsp;any Dividend Equivalents associated with any other Award shall be subject to the same vesting conditions as the shares subject to such Award to
which the Dividend Equivalents relate, and shall be forfeited to the extent the Award is forfeited or otherwise not earned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>7.06</B>&#8195;&#8194;&#8196;<B>Performance Shares and Performance Units</B>. The Committee is authorized to grant Performance Shares and
Performance Units to Eligible Persons, subject to the following terms and conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Performance Shares shall be denominated in shares of Stock. Performance Units shall be denominated in dollars
and have an initial value that is established by the Committee at the time of grant. The Committee shall set performance goals in its discretion which, depending on the extent to which they are met, will determine the number and/or value of
Performance Units or Performance Shares that will be paid out to the Participant, and shall set a performance period in accordance with Section&nbsp;8.01. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After the applicable performance period has ended, the holder of Performance Units or Performance Shares shall
be entitled to receive payout on the number and value of Performance Units or Performance Shares earned by the Participant over the performance period, to be determined as a function of the extent to which the corresponding performance goals have
been achieved. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless the Performance Shares or Performance Units are deferred as provided in Section&nbsp;6.08, payment of
earned Performance Units and Performance Shares shall be made in a single lump sum, as soon as practicable after the Committee has determined the number of Performance Units or Performance Shares earned for the performance period, but no later than
the 15th day of the third month after the later of (a)&nbsp;the last day of the first calendar year in which the Participant&#146;s rights to such Units/Shares have become vested </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
and nonforfeitable and the Substantial Risk of Forfeiture has lapsed or (b)&nbsp;the last day of the Company&#146;s first fiscal year in which the Participant&#146;s rights to such Units/Shares
have become vested and nonforfeitable and the Substantial Risk of Forfeiture has lapsed. Except as otherwise provided in an Award Agreement, the Committee shall pay earned Performance Shares in Stock but may in its sole discretion and as set forth
in the Award Agreement pay earned Performance Units in the form of cash or in Stock (or in a combination thereof) which have an aggregate Fair Market Value equal to the value as of the date of distribution of the number of earned Performance Units
at the close of the applicable performance period. Such Stock may be made subject to any further restrictions deemed appropriate by the Committee. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless otherwise provided in the Award Agreement, Participants shall be entitled to receive Dividend
Equivalents paid with respect to Stock which has been earned and become vested as of the close of the performance period in connection with grants of Performance Units or Performance Shares but not yet distributed to Participants, provided that any
such Dividend Equivalents shall in all cases be subject to the same terms and conditions as apply to Dividends Equivalents earned with respect to RSUs as set forth in Section&nbsp;7.04(b). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>7.07</B>&#8195;&#8194;&#8196;<B>Annual Equity Grants, Deferred Stock Units and Deferrals for
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</B>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless the Board or the Committee sets a different equity award policy for
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors, but subject to the limitation in Section&nbsp;5.03, on the date specified by the Committee of each year, each <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director shall receive
a fully vested annual grant of shares of Stock (an &#147;Annual Equity Grant&#148;), with the number determined by dividing a dollar amount by the Fair Market Value of a share of Stock on the date of the Annual Equity Grant. Except as otherwise
determined by the Board or the Committee, if the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director has then not served for the full period since the date of the prior Annual Equity Grant, his or her Annual Equity Grant shall be a <FONT
STYLE="white-space:nowrap">pro-rata</FONT> grant based on the full months of service as a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director since the date of the prior Annual Equity Grant. The dollar amount shall be such amount as may be
approved by the Committee from time to time as part of its periodic evaluation of <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director compensation. Unless deferred under subsection (b)&nbsp;below, the Annual Equity Grant shall be
immediately distributed in Stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director may elect to defer all or any part (in 10%
increments) of his or her Annual Equity Grant into either deferred stock units (&#147;DSUs&#148;) or, to the extent permitted by the Committee, into the account (the &#147;Deferred Cash Compensation Account&#148;) established under subsection
(c)&nbsp;below. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An election to defer the Annual Equity Grant shall be made on or before December&nbsp;31 of the calendar year
preceding the calendar year in which the <FONT STYLE="white-space:nowrap">12-month</FONT> period over which the Annual Equity Grant is earned begins (except for a new <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director, in which event
Section&nbsp;6.08(b) shall apply), on a form (which may be electronic) prescribed by the Company. Notwithstanding the foregoing, if an Annual Equity Grant is subject to a condition requiring the <FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Director to remain in continuous service for a period of at least 12 months, the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director may elect to defer such Annual Equity Grant on or before the 30th day after the first day of such period,
provided that the election is made at least 12 months in advance of the earliest vesting date (other than vesting on account of death or a Change in Control). An election to defer an Annual Equity Grant shall become irrevocable for the period to
which it applies as of the last date for making such election. Notwithstanding Section&nbsp;6.08(a), a deferral election under this subsection (b)&nbsp;shall carry over from year to year, unless changed or revoked at the same time and in the same
manner as the a deferral election could be made under this subsection (b). The deferral election </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
shall include (i)&nbsp;the designation and portion of the Annual Equity Grant to be deferred, (ii)&nbsp;whether it shall be deferred into DSUs or, if permitted by the Committee, into the Deferred
Cash Compensation Account and (iii)&nbsp;to the extent the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director elects an alternative time and form of payment pursuant to clause&nbsp;(iv) of this Section&nbsp;7.07(b) or clause&nbsp;(iv) of
Section&nbsp;7.07(c), below, the time and form of payment of the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s DSUs or Deferred Cash Compensation Account, as applicable. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The value of any DSU at any time shall be the Fair Market Value of one share of Stock. Prior to the conversion
of DSUs to a cash-denominated deferral account pursuant to clause (iii)&nbsp;below or the settlement of DSUs in Stock, Dividend Equivalents shall be earned on DSUs and converted into additional DSUs based on the Fair Market Value of the Stock on the
date the dividends are converted. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Except to the extent a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director elects an alternative time
and form of payment pursuant to clause (iv)&nbsp;below, DSUs will be converted to a cash-denominated deferral account as of the date of the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Termination of Service, in an amount
equal to the Fair Market Value of the DSUs as of such date, and such account shall be paid out in cash in two installments. The first installment shall be paid within 30 days after the date of the <FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Director&#146;s Termination of Service in an amount equal to <FONT STYLE="white-space:nowrap">one-half</FONT> of the value of such deferral account. The second installment shall be paid on the first annual anniversary of the first installment
payment in an amount equal to the remaining value of such deferral account; provided that during the period beginning on the date of the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Termination of Service and prior to payment
of the second installment, such account will be credited with interest on a monthly basis at a monthly compounding rate (the &#147;Prime Borrowing Rate&#148;) equal to the prime lending rate of interest in effect as of the first business day of that
month as quoted by the Company&#146;s then-current lending bank financing source for commercial borrowings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In lieu of the time and form of payment prescribed by clause (iii)&nbsp;above, a
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director may elect either or both of the following: (A)&nbsp;that all of his or her DSUs be paid or commence within 30 days after the date of the
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Termination of Service and be paid in the form of a <FONT STYLE="white-space:nowrap">lump-sum</FONT> distribution or in annual installments payable over a period of five, ten or 15
years and/or (B)&nbsp;that all of his or her DSUs be credited and paid in the form of an equal number of shares of Stock; provided that if a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director has previously made an election to defer any
Annual Equity Grants in the form of DSUs, (x)&nbsp;any subsequent election with respect to the time or form of payment pursuant to clause (A)&nbsp;above shall not take effect until the <FONT STYLE="white-space:nowrap">12-month</FONT> anniversary of
the date of such election, and shall take effect only if the previously-scheduled payment date does not occur within such <FONT STYLE="white-space:nowrap">12-month</FONT> period, and (y)&nbsp;the <FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Director must elect that, notwithstanding clause (A)&nbsp;above, the DSUs be paid or commence on a date that is at least five years after the date on which the DSUs otherwise would have been paid or commenced and in no event shall installments
continue later than 15 years after the date of such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Termination of Service. For purposes of Section&nbsp;409A of the Code, a right to receive installment payments pursuant to this
Section&nbsp;7.07(b) shall be treated as a right to receive a single payment. Unless the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director elects to receive a distribution in the form of shares of Stock, then following the date of the <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Termination of Service and prior to the date on which the DSUs are paid in full, the unpaid DSUs will be credited with interest on a monthly basis at the Prime Borrowing Rate. If a <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director elects to receive his or her DSUs in the form of installments, and the value of such DSUs is less than $10,000 as of the date of such <FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Director&#146;s </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Termination of Service or any anniversary thereof, then the unpaid portion of such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s DSUs shall be distributed to such <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director in a <FONT STYLE="white-space:nowrap">lump-sum</FONT> distribution. Within 90 days after the date of a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s death, all unpaid
installments shall accelerate and be paid to the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s beneficiary or estate in a lump sum payment. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director may elect to defer all or any part (in 10%
increments) of his or her annual retainer, committee fees, meeting fees, or any similar fees for service as a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director (&#147;Directors Fees&#148;), plus, to the extent permitted by the Committee,
all or any portion (in 10% increments) of his or her Annual Equity Grant, into a Deferred Cash Compensation Account. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An election to defer Directors Fees into the Deferred Cash Compensation Account shall be made on or before
December&nbsp;31 of the calendar year preceding the calendar year in which the Directors Fees are earned (except for a new <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director, in which event Section&nbsp;6.08(b) shall apply), on a form
(which may be electronic) prescribed by the Company. Such election shall become irrevocable for the period to which it applies as of the last date for making such election. Notwithstanding Section&nbsp;6.08(a), a deferral election under this
subsection (c)&nbsp;shall carry over from year to year, unless changed or revoked at the same time and in the same manner as a deferral election could be made under this subsection (c). The deferral election shall include (i)&nbsp;the designation
and portion of the Directors Fees to be deferred and (ii)&nbsp;to the extent the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director elects an alternative time of payment pursuant to clause&nbsp;(iv) below, the time of payment of the <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Deferred Cash Compensation Account. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Deferred Cash Compensation Account shall accrue interest on a monthly basis at a monthly compounding rate
equal to 120% of the applicable federal midterm rate (as determined under Section&nbsp;1274(d) of the Code) until the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Termination of Service. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Except to the extent a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director elects an alternative time
of payment pursuant to clause (iv)&nbsp;below or, if permitted by the Committee, Section&nbsp;7.07(b) above, the Deferred Cash Compensation Account will be paid out in cash in two installments. The first installment shall be paid within 30 days
after the date of the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Termination of Service in an amount equal to <FONT STYLE="white-space:nowrap">one-half</FONT> of the balance of his or her Deferred Cash Compensation Account.
The second installment shall be paid on the first annual anniversary of the first installment payment in an amount equal to the remaining balance of the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Deferred Cash Compensation
Account. Following the date of the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Termination of Service and prior to the payment of the second installment, the Deferred Cash Compensation Account will be credited with interest
on a monthly basis at Prime Borrowing Rate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In lieu of the time of payment prescribed by clause (iii)&nbsp;above, a
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director may elect that all of his or her Deferred Cash Compensation Account be paid or commence within 30 days after the date of the <FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Director&#146;s Termination of Service and be paid in the form of a lump sum distribution or in annual installments payable over a period of five, ten or 15 years; provided that if a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director has
previously made an election to defer any Directors Fees or Annual Equity Grants to his or her Deferred Cash Compensation Account, (x)&nbsp;any subsequent election with respect to the time of payment pursuant to this clause&nbsp;(iv) shall not take
effect<I> </I>until the <FONT STYLE="white-space:nowrap">12-month</FONT> anniversary of the date of such election, and shall take effect only if the previously scheduled payment date does not occur within such
<FONT STYLE="white-space:nowrap">12-month</FONT> period, and (y)&nbsp;the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director must </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
elect that, notwithstanding clause&nbsp;(A) above, the Deferred Cash Compensation Account be paid or commence on a date that is at least five years after the date on which the Deferred Cash
Compensation Account otherwise would have been paid or commenced and in no event shall installments continue later than 15 years after the date of such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Termination of Service. For
purposes of Section&nbsp;409A of the Code, a right to receive installment payments pursuant to this Section&nbsp;7.07(c) shall be treated as a right to receive a single payment. Following the date of the
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Termination of Service and prior to full payment of the Deferred Cash Compensation Account, the Deferred Cash Compensation Account will be credited with interest on a monthly basis
at the Prime Borrowing Rate. If a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director elects to receive his or her Deferred Cash Compensation Account in the form of installments, and the value of such Deferred Cash Compensation Account is
less than $10,000 as of the date of such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Termination of Service or any anniversary thereof, then the unpaid portion of such <FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Director&#146;s Deferred Cash Compensation Account shall be distributed to such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director in a <FONT STYLE="white-space:nowrap">lump-sum</FONT> distribution. Within 90 days after the date of a <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s death, all unpaid installments shall accelerate and be paid to the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s beneficiary or estate in a lump sum payment.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Annual Equity Grants, DSUs, and the Deferred Cash Compensation Account, shall be fully vested at all times.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Committee may from time to time establish other compensation and deferral arrangements for <FONT
STYLE="white-space:nowrap">Non-employee</FONT> Directors in addition to or in lieu of the program outlined above in this Section&nbsp;7.07. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>7.08</B>&#8195;&#8194;&#8196;<B>Bonus Stock and Other Awards</B>. The Committee is authorized, subject to limitations under applicable law,
to grant to Eligible Persons other Awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, shares of Stock or factors that may influence the value of shares of Stock, including,
without limitation, convertible or exchangeable debt securities, other rights convertible or exchangeable into shares of Stock, purchase rights for shares of Stock, Awards with value and payment contingent upon performance of the Company or business
units thereof or any other factors designated by the Committee, and Awards valued by reference to the book value of shares of Stock or the value of securities of or the performance of specified subsidiaries or Affiliates or other business units. The
Committee is authorized to grant shares of Stock as a bonus, or to grant shares of stock or other Awards in lieu of obligations of the Company or an Affiliate to pay cash or deliver other property under the Plan or under other plans or compensatory
arrangements, subject to such terms as shall be determined by the Committee. The Committee shall determine the terms and conditions of such Awards, which may include the right to elective deferral thereof, subject to such terms and conditions as the
Committee may specify in its discretion. Stock delivered pursuant to an Award in the nature of a purchase right granted under this Section shall be purchased for such consideration, paid for at such times, by such methods, and in such forms,
including, without limitation, cash, shares of Stock, other Awards, or other property, as the Committee shall determine, subject to any applicable restrictions of this Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>7.09</B>&#8195;&#8194;&#8196;<B>Cash Awards</B>. The Committee is authorized to grant cash Awards to Eligible Persons as a bonus on such
terms and condition as the Committee shall determine, subject to any applicable restrictions of this Plan. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>VIII.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Performance Awards </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>8.01</B>&#8195;&#8194;&#8196;<B>Performance Awards Generally</B>. The Committee is authorized to grant any Award in the form of a
Performance Award. Performance Awards may be denominated as a cash amount, number of shares of Stock, or specified number of other Awards or property (or a combination) which may be earned upon achievement or satisfaction of performance conditions
specified by the Committee over a performance period established by the Committee. In addition, the Committee may specify that any other Award shall constitute a Performance Award by conditioning the right of a Participant to exercise the Award or
have it settled, and the timing thereof, upon achievement or satisfaction of such performance conditions as may be specified by the Committee. The Committee </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may use such business criteria and other measures of performance as it may deem appropriate in establishing any performance conditions. After the end of each performance period, the Committee
shall determine the amount, if any, of the Performance Award for that performance period payable to each Participant. The Committee may, in its discretion, determine that the amount payable to any Participant as a Performance Award shall be reduced
from the amount of his or her potential Performance Award, including a determination to make no final Award whatsoever, and may exercise its discretion to increase the amounts payable under any Performance Award. The Committee shall specify the
circumstances in which such Performance Awards shall be paid or forfeited in the event of Termination of Service by the Participant or other event (including a Change in Control) prior to the end of a performance period or otherwise prior to
settlement of such Performance Awards. Settlement of Performance Awards shall be in cash, Stock, other Awards or other property, as provided in the Award Agreement in the discretion of the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>8.02</B>&#8195;&#8194;&#8196;<B>Performance Criteria</B>. A Performance Award may be subject to any performance criteria selected by the
Committee, including without limitation the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Sales, on a corporate, divisional or unit basis, including (i)&nbsp;net sales; (ii)&nbsp;unit sales volume;
(iii)&nbsp;aggregate product price; (iv)&nbsp;same store sales or (v)&nbsp;comparable store sales; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Share price, including (i)&nbsp;market price per share; and (ii)&nbsp;share price appreciation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Earnings, on a corporate, divisional or unit basis, including (i)&nbsp;earnings per share, reflecting dilution
of shares; (ii)&nbsp;gross or <FONT STYLE="white-space:nowrap">pre-tax</FONT> profits; <FONT STYLE="white-space:nowrap">(iii)&nbsp;post-tax</FONT> profits; (iv)&nbsp;operating profit; (v)&nbsp;earnings net of or including dividends;
(vi)&nbsp;earnings net of or including the after-tax cost of capital; (vii)&nbsp;earnings before (or after) interest and taxes (&#147;EBIT&#148;); (viii) earnings per share from continuing operations, diluted or basic; (ix)&nbsp;earnings before (or
after) interest, taxes, depreciation and amortization (&#147;EBITDA&#148;); (x) <FONT STYLE="white-space:nowrap">pre-tax</FONT> operating earnings after interest and before incentives, service fees and extraordinary or special items;
(xi)&nbsp;operating earnings; (xii)&nbsp;growth in earnings or growth in earnings per share; and (xiii)&nbsp;total earnings; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Return on equity, on a corporate, divisional or unit basis; including (i)&nbsp;return on equity;
(ii)&nbsp;return on invested capital; (iii)&nbsp;return or net return on assets; (iv)&nbsp;return on net assets; (v)&nbsp;return on gross sales; (vi)&nbsp;return on investment; (vii)&nbsp;return on capital; (viii)&nbsp;return on committed capital;
(ix)&nbsp;financial return ratios; (x)&nbsp;value of assets; and (xi)&nbsp;change in assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Cash flow(s), on a corporate, divisional or unit basis, including (i)&nbsp;operating cash flow; (ii)&nbsp;net
cash flow; (iii)&nbsp;free cash flow; (iv)&nbsp;cash flow on investment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Revenue, on a corporate, divisional or unit basis, including (i)&nbsp;gross or net revenue; and
(ii)&nbsp;changes in annual revenues; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Margins, on a corporate, divisional or unit basis, including (i)&nbsp;adjusted
<FONT STYLE="white-space:nowrap">pre-tax</FONT> margin; and (ii)&nbsp;operating margins; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Income, on a corporate, divisional or unit basis, including (i)&nbsp;net income; and (ii)&nbsp;consolidated net
income; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Economic value added; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Costs, on a corporate, divisional or unit basis, including (i)&nbsp;operating or administrative expenses;
(ii)&nbsp;operating expenses as a percentage of revenue; (iii)&nbsp;expense or cost levels; (iv)&nbsp;reduction of losses, loss ratios or expense ratios; (v)&nbsp;reduction in fixed costs; (vi)&nbsp;expense reduction levels; (vii)&nbsp;operating
cost management; and (viii)&nbsp;cost of capital; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Financial ratings, on a corporate, divisional or unit basis, including (i)&nbsp;credit rating;
(ii)&nbsp;capital expenditures; (iii)&nbsp;debt; (iv) debt reduction; (v)&nbsp;working capital; (vi)&nbsp;average invested capital; and (vii)&nbsp;attainment of balance sheet or income statement objectives; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Market or category share, on a corporate, divisional or unit basis, including (i)&nbsp;market share;
(ii)&nbsp;volume; (iii) unit sales volume; and (iv)&nbsp;market share or market penetration with respect to specific designated products or product groups and/or specific geographic areas; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shareholder return, including (i)&nbsp;total shareholder return, shareholder return based on growth measures or
the attainment of a specified share price for a specified period of time; and (ii)&nbsp;dividends; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nonfinancial performance criteria on a corporate, divisional or unit basis, including (i)&nbsp;attainment of
strategic and business goals; (ii)&nbsp;regulatory compliance; (iii)&nbsp;productivity and productivity improvements; (iv)&nbsp;inventory turnover, average inventory turnover or inventory controls; (v)&nbsp;net asset turnover; (vi)&nbsp;customer
satisfaction; (vii)&nbsp;employee satisfaction; (viii)&nbsp;employee diversity goals; (ix)&nbsp;employee turnover; (x)&nbsp;environmental goals; (xi)&nbsp;social goals; (xii)&nbsp;goals in corporate ethics and integrity; (xiii)&nbsp;safety goals;
(xiv)&nbsp;business integration goals; (xv)&nbsp;business expansion goals or goals relating to acquisitions or divestitures; and (xvi)&nbsp;succession plan development and implementation. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In establishing a Performance Award or determining the achievement of an applicable performance measure, the Committee may provide that achievement of a
performance measure may be amended or adjusted to include or exclude components of such performance measure, including, without limitation, foreign exchange gains and losses, asset write-downs, litigation or claim judgments or settlements,
acquisitions and divestitures, changes in fiscal year, unbudgeted capital expenditures, special charges such as restructuring or impairment charges, debt refinancing costs, annual incentive payments or other bonuses, capital charges, extraordinary
or noncash items, unusual, infrequently occurring, nonrecurring or <FONT STYLE="white-space:nowrap">one-time</FONT> events affecting the Company or its financial statements or changes in law or accounting principles. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>IX.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Change in Control </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in the Award Agreement, in the event there is any Change in Control, the Committee may, in its discretion, with
respect to any Award or agreement that is not 409A Compensation, without the consent of the Participant, provide for any or all of the following to occur: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the assumption or substitution of, or adjustment to, such outstanding Award or agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">acceleration of the vesting of such Award and termination of any restrictions or performance conditions on such
Award, either immediately upon the Change in Control or upon the Termination of Service of the Participant within a fixed time following the Change in Control, as determined by the Committee; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the cancellation of such Award or agreement for a payment to the Participant in cash or other property in an
amount determined by the Committee. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">In addition, with respect to any unexercised Option or SAR, the Committee may
extend the period for exercising the vested portion thereof for a stated period following such a Termination of Service within such fixed time (but only during the stated term of the Option or SAR). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>X.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>General Provisions </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.01</B>&#8195;&#8194;&#8196;<B>Additional Award Forfeiture Provisions</B>. The Committee may condition an Eligible Person&#146;s right to
receive a grant of an Award, or a Participant&#146;s right to exercise an Award, to retain Stock, cash or other property acquired in connection with an Award, or to retain the profit or gain realized by a Participant in connection with an
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Award, including cash or other property received upon sale of Stock acquired in connection with an Award, upon the Participant&#146;s compliance with specified conditions relating to <FONT
STYLE="white-space:nowrap">non-competition,</FONT> confidentiality of information relating to the Company, <FONT STYLE="white-space:nowrap">non-solicitation</FONT> of customers, suppliers, and employees of the Company, cooperation in litigation, <FONT
STYLE="white-space:nowrap">non-disparagement</FONT> of the Company and its officers, Directors and Affiliates, or other requirements applicable to the Participant, as determined by the Committee, at the time of grant or otherwise, including during
specified periods following Termination of Service Nothing contained in this Section&nbsp;10.01 or an Award is intended to limit the Participant&#146;s ability to (i)&nbsp;report possible violations of law or regulation to, or file a charge or
complaint with, the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Department of Justice, the Congress, any Inspector
General, or any other federal, state or local governmental agency or commission (&#147;Government Agencies&#148;), (ii)&nbsp;communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted
by any Government Agency, including providing documents or other information, without notice to the Company or (iii)&nbsp;under applicable United States federal law to (A)&nbsp;disclose in confidence trade secrets to federal, state, and local
government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law or (B)&nbsp;disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under
seal and protected from public disclosure. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>10.02</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Compliance with Legal and Other Requirements. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may, to the extent deemed necessary or advisable by the Committee, postpone the issuance or
delivery of Stock or payment of other benefits under any Award until completion of such registration or qualification of such Stock or other required action under any federal or state law, rule or regulation (including, without limitation, obtaining
any approval, order or ruling from the Securities and Exchange Commission, the Internal Revenue Service or any other governmental agency that the Committee or the Company shall determine to be necessary or advisable), listing or other required
action with respect to any stock exchange or automated quotation system upon which the Stock or other securities of the Company are listed or quoted, or compliance with any other obligation of the Company, as the Company may consider appropriate,
and may require any Participant, as a condition of receiving payment under an Award or delivery of Stock under an Award, to make such representations and covenants, furnish such information and comply with or be subject to such other conditions as
the Company deems necessary or advisable in connection with the issuance or delivery of Stock or payment of other benefits in compliance with applicable laws, rules, and regulations, listing requirements, or other obligations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Without limiting the generality of the foregoing, no Stock or other form of payment shall be delivered with
respect to any Award unless the Company shall be satisfied based on the advice of its counsel that such issuance will be in compliance with applicable federal, state and other securities laws. All certificates, or book-entry accounts, for shares of
Stock delivered under the Plan shall be subject to such stop-transfer orders and other restrictions as the Company may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange
upon which Stock is then listed and any applicable federal, state or other securities laws, and the Company may cause a legend or legends to be placed on any such certificates, or notations on such book-entry accounts, to make appropriate reference
to such restrictions. The foregoing provisions of this Section&nbsp;10.02(b) shall not be effective with respect to Awards held by United States residents (a)&nbsp;if and to the extent that the shares of Stock delivered under the Plan are covered by
an effective and current registration statement under the Securities Act of 1933, as amended, and the Stock is a &#147;covered security&#148; within the meaning of Section&nbsp;18 of the Securities Act of 1933, as amended, or (b)&nbsp;if and so long
as the Company determines that application of such provisions are no longer required or desirable. Without limiting the foregoing, the Committee may impose such restrictions, conditions or limitations as it determines appropriate as to the timing
and manner of any resales by a Participant or other subsequent transfers by a Participant of any shares of Stock delivered under the Plan, including, without limitation, restrictions under the Company&#146;s insider trading policy and restrictions
as to the use of a specified brokerage firm for such resales or other transfers. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.03</B>&#8195;&#8194;&#8196;<B>Designation of Beneficiary</B>. By written instrument
filed with the Company during the Participant&#146;s lifetime in a manner specified by the Committee in the Award Agreement or in the Committee&#146;s rules and procedures of general application, each Participant may file with the Committee a
written designation of one or more persons or revocable trusts as the Beneficiary who shall be entitled to receive the amount, if any, payable hereunder after the Participant&#146;s death or to exercise an Award or to receive settlement of an Award
after the Participant&#146;s death. No such designation of Beneficiary shall be effective until filed with the Company. A Participant may, from time to time, revoke or change his or her Beneficiary designation without the consent of any prior
Beneficiary by filing a new designation with the Company. The last such designation received by the Company prior to the Participant&#146;s death shall be controlling. If no such Beneficiary designation is in effect at the time of the
Participant&#146;s death, or if no designated Beneficiary survives the Participant, the Participant&#146;s estate shall be deemed to have been designated his or her Beneficiary and the executor or administrator thereof shall receive the amount, if
any, payable hereunder and shall be entitled to exercise or receive settlement of an Award after the Participant&#146;s death. If the Committee is in doubt as to the right of any person as Beneficiary, the Company may retain any amount in question
until the rights thereto are determined, or the Company may pay such amount into any court of appropriate jurisdiction and such payment shall be a complete discharge of the liability of the Company therefor. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>10.04</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Tax Provisions. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Withholding. </I>The Company and any Affiliate is authorized to withhold, at the time of grant or settlement
or other time as appropriate, from any Award or account, any payment relating to an Award or account, including from a distribution of Stock, or any payroll or other payment to a Participant, amounts of withholding and other taxes required to be
withheld by the Company or Affiliate. This authority shall include authority to withhold or receive Stock or other property and to make cash payments in respect thereof in satisfaction of the Company&#146;s (or an Affiliate&#146;s) withholding
obligations in the discretion of the Committee. Unless the Committee otherwise specifies, Participants shall satisfy withholding tax amounts by having the Company (or an Affiliate) withhold from the Stock to be delivered upon exercise of an Option
or vesting or settlement of an Award that whole number of shares of Stock having a Fair Market Value equal to the amount to be withheld, and any additional withholding amount shall be satisfied in cash. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Required Consent to and Notification of Section</I><I></I><I>&nbsp;83(b) Election of the Code. </I>No
election under Section&nbsp;83(b) of the Code (to include in gross income in the year of transfer the amounts specified in Section&nbsp;83(b) of the Code) or under a similar provision of the laws of a jurisdiction outside the United States may be
made unless expressly permitted by the terms of the Award Agreement or by action of the Committee in writing prior to the making of such election. In any case in which a Participant is permitted to make such an election in connection with an Award,
the Participant shall notify the Committee of such election within ten days of filing notice of the election with the Internal Revenue Service or other governmental authority, in addition to any filing and notification required pursuant to
regulations issued under Section&nbsp;83(b) of the Code or other applicable provision. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Requirement of Notification Upon Disqualifying Disposition Under Section</I><I></I><I>&nbsp;421(b) of the
Code. </I>If any Participant shall make any disposition of shares of Stock delivered pursuant to<I> </I>the exercise of an ISO under the circumstances described in Section&nbsp;421(b) of the Code (relating to certain disqualifying dispositions),
such Participant shall notify the Committee of such disposition within ten days thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Payment of Tax Amount. </I>Notwithstanding anything herein <I>to </I>the contrary, in the event the Internal
Revenue Service should finally determine that an Award that has not been settled is nevertheless required to be included in the Participant&#146;s or a Beneficiary&#146;s gross income for federal income tax purposes, then an amount necessary to pay
the applicable federal, state or local income taxes on such includible value shall be distributed with respect to the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Award in a lump sum cash payment within sixty&nbsp;(60) days after such determination, without the requirement of separate approval by the Committee. A &#147;final determination&#148; of the
Internal Revenue Service is a determination in writing ordering the payment of additional tax, reporting of additional gross income or otherwise requiring an account or portion thereof to be included in gross income, which is not appealable or which
the Participant or Beneficiary does not appeal within the time prescribed for appeals. For avoidance of doubt, this Section&nbsp;10.04(d) applies to all Awards and accounts, including both 409A Compensation and
<FONT STYLE="white-space:nowrap">non-409A</FONT> Compensation. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Participant Responsibility. </I>Each Participant is solely responsible for all taxes of any nature imposed
on the Participant in connection with any Award, including without limitation any taxes under Section&nbsp;409A or Section&nbsp;4999 of the Code. Nothing in this Plan or any Award Agreement shall be construed to guarantee the tax consequences to the
Participant of any Award. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>10.05</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Limitation on Benefits. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To the extent that any payment or distribution to or for the benefit of a Participant pursuant to the terms of
this Plan or any other plan, arrangement or agreement with the Company, any of its affiliated companies, any person whose actions result in a change of ownership or effective control covered by Section&nbsp;280G(b)(2) of the Code or any person
affiliated with the Company or such person, whether paid or payable or distributed or distributable pursuant to the terms of this Plan or otherwise (the &#147;Payments&#148;) would be subject to the excise tax (the &#147;Excise Tax&#148;) imposed by
Section&nbsp;4999 of the Code, then the Company shall reduce the Payments to the amount that is (after taking into account federal, state, local and social security taxes at the maximum marginal rates, including any excise taxes imposed by
Section&nbsp;4999 of the Code) one dollar less than the amount of the Payments that would subject the Participant to the Excise Tax (the &#147;Safe Harbor Cap&#148;) if, and only if, such reduction would result in the Participant receiving a higher
net <FONT STYLE="white-space:nowrap">after-tax</FONT> amount. Unless a Participant shall have given prior written notice specifying a different order to the Company to effectuate the Safe Harbor Cap, the Payments to be reduced hereunder will be
determined in a manner which has the least economic cost to the Participant and, to the extent the economic cost is equivalent, will be reduced in the reverse order of when the Payment would have been made to the Participant until the reduction
specified herein is achieved. A Participant&#146;s right to specify the order of reduction of the Payments shall apply only to the extent that it does not directly or indirectly alter the time or method of payment of any amount that is deferred
compensation subject to (and not exempt from) Section&nbsp;409A. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All determinations required to be made under this Section&nbsp;10.05, including whether and when the Safe
Harbor Cap is required and the amount of the reduction of the Payments pursuant to the Safe Harbor Cap and the assumptions to be utilized in arriving at such determination, shall be made by a public accounting firm or other nationally recognized
consulting firm with expertise in Section&nbsp;280G of the Code that is retained by the Company as of the date immediately prior to the Change in Control (the &#147;Calculating Firm&#148;) which shall provide detailed supporting calculations both to
the Company and the Participant within fifteen (15)&nbsp;business days of the receipt of notice from the Company or the Participant that there has been a Payment, or such earlier time as is requested by the Company (collectively, the
&#147;Determination&#148;). All fees and expenses of the Calculating Firm shall be borne solely by the Company and the Company shall enter into any agreement requested by the Calculating Firm in connection with the performance of the services
hereunder. The Determination by the Calculating Firm shall be binding upon the Company and the Participant. The Company shall bear and pay directly all costs and expenses incurred in connection with any contests or disputes with the Internal Revenue
Service relating to the Excise Tax, and the Participant shall cooperate, to the extent his or her reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses are reimbursed by the Company, with
any reasonable requests by the Company in connection with any such contests or disputes. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.06</B>&#8195;&#8194;&#8196;<B>Amendment and Termination of the Plan</B>. The Company,
acting through the Board or the Committee, may at any time terminate, and from time to time may amend or modify the Plan; provided, however, that no amendment or modification may become effective without approval of the amendment or modification by
the stockholders if (i)&nbsp;stockholder approval is required to enable the Plan to satisfy any applicable federal or state statutory or regulatory requirements or applicable exchange listing requirements, or (ii)&nbsp;such amendment or modification
seeks to modify the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director compensation limit set forth in Section&nbsp;5.03 or the prohibition on repricing set fort in Section&nbsp;10.07; and provided further, that, without the consent of an
affected Participant, no such Board or Committee action may materially and adversely affect the rights of such Participant under any outstanding Award (for this purpose, actions that alter the timing of federal income taxation of a Participant will
not be deemed material unless the Board or the Committee determines that such action would result in an income tax penalty on the Participant). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.07</B>&#8195;&#8194;&#8196;<B>No Repricing</B>. Without the approval of stockholders and except in connection with a Change in Control
or the adjustment provisions set forth in Section&nbsp;5.04, the Committee will not amend or replace previously granted Options or SARs in a transaction that constitutes a &#147;repricing,&#148; within the meaning of the listing requirements of the
Nasdaq Stock Market. In addition, and for avoidance of doubt, none of the following is permitted to occur without approval of stockholders: (a)&nbsp;lowering the grant price of outstanding Options and SARs, and (b)&nbsp;cancelling outstanding
Options and SARs in exchange for cash, other Awards, or replacement Options and SARs with grant prices that are less than the grant prices of the cancelled Options or SARs, in each case, other than in connection with a Change in Control or the
adjustment provisions set forth in Section&nbsp;5.04. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.08</B>&#8195;&#8194;&#8196;<B>Clawback; Right of Setoff</B>. Awards are
subject to the Company&#146;s policy on recoveries and such other terms and conditions as the Committee may impose, including, without limitation, the Company&#146;s Policy on Recoupment of Compensation Due to Improper Conduct and the Company&#146;s
Policy on Recoupment of Incentive Compensation, in both cases as applicable. The Company or any Affiliate may, to the extent permitted by applicable law, deduct from and set off against any amounts the Company or an Affiliate may owe to the
Participant from time to time, including amounts payable in connection with any Award, owed as wages, fringe benefits, or other compensation owed to the Participant, such amounts as may be owed by the Participant to the Company, although the
Participant shall remain liable for any part of the Participant&#146;s payment obligation not satisfied through such deduction and setoff. By accepting any Award granted hereunder, the Participant agrees to any deduction or setoff under this
Section. Notwithstanding the foregoing, no setoff form 409A Compensation may be made if it results in acceleration or deferral of the permitted payment date under Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.09</B>&#8195;&#8194;&#8196;<B>Nonexclusivity of the Plan</B>. Neither the adoption of the Plan by the Board nor its submission to the
stockholders of the Company for approval shall be construed as creating any limitations on the power of the Board or a committee thereof to adopt such other incentive arrangements, apart from the Plan, as it may deem desirable, and such other
arrangements may be either applicable generally or only in specific cases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.10</B>&#8195;&#8194;&#8196;<B>Treatment of Awards by
Other Plans</B>. No Award shall be treated as compensation for the purpose of determining benefits based on compensation under any other plan or arrangement of the Company or any Affiliate unless such plan or arrangement provides to the contrary
making specific reference to this Plan or to such form of compensation under the Former Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.11</B>&#8195;<B>&#8194;&#8196;Payments in the Event of Forfeitures; Fractional Shares</B>. Unless otherwise determined by the Committee,
in the event of a forfeiture of an Award with respect to which a Participant paid cash consideration, the Participant shall be repaid the amount of such cash consideration, or if less, the Fair Market Value on the date of forfeiture of the Stock for
which the Participant paid. Distributions in Stock shall be made in whole and fractional shares, unless the Company elects to pay fractional shares in cash. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>10.12</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Considerations Under Section&nbsp;409A of the Code. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Construction in Compliance </I>with <I>Section</I><I></I><I>&nbsp;409A of the Code. </I>The Company intends
that none of the grant, exercise, settlement or amendment or termination of any Award under the Plan will cause the Participant to be liable for payment of interest or a tax penalty under Section&nbsp;409A of the Code. The provisions of the Plan and
any Award Agreement shall be construed consistent with that intent. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I><FONT STYLE="white-space:nowrap">Six-Month</FONT> Delay. </I>Any distribution or settlement of 409A
Compensation triggered by the Termination of Service of a Specified Employee that would otherwise be made prior to the Deferred Distribution Date (as defined below) shall not occur earlier than the Deferred Distribution Date. The &#147;Deferred
Distribution Date&#148; is the day that is six (6)&nbsp;months and one (1)&nbsp;day after a Participant&#146;s Termination of Service (or the Specified Employee&#146;s date of death, if earlier). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.13</B>&#8195;&#8194;&#8196;<B>Governing Law</B>. The Plan and all agreements and forms hereunder shall be construed in accordance with
and governed by the laws of the State of Delaware without giving effect to principles of conflicts of laws, and applicable provisions of federal law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.14</B>&#8195;&#8194;&#8196;<B>Awards to Participants Outside the United States</B>. The Committee may adopt rules and procedures
relating to the operation and administration of the Plan to accommodate the specific requirements of local laws and procedures for a Participant or group of participants who are then resident or primarily employed outside of the United States.
Without limiting the generality of the foregoing, the Committee is specifically authorized (a)&nbsp;to adopt the rules and procedures regarding the conversion of local currency, withholding procedures and handling of evidence of Stock ownership
which vary with local requirements; (b)&nbsp;to adopt <FONT STYLE="white-space:nowrap">sub-plans,</FONT> and Plan addenda as the Committee deems desirable, to accommodate foreign laws, regulations and practice; and (c)&nbsp;to modify the terms of
any Award under the Plan in any manner deemed by the Committee to be necessary or appropriate in order that such Award shall conform to laws, regulations, and customs of the country in which the Participant is then resident or primarily employed, or
so that the value and other benefits of the Award to the Participant, as affected by foreign tax laws and other restrictions applicable as a result of the Participant&#146;s residence or employment abroad shall be comparable to the value of such an
Award to a Participant who is resident or primarily employed in the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.15</B>&#8195;&#8194;&#8196;<B>Limitation on
Rights Conferred under Plan</B>. Neither the Plan nor any action taken hereunder shall be construed as (i)&nbsp;giving any Eligible Person or Participant the right to continue as an Eligible Person or Participant or in the employ or service of the
Company or an Affiliate, (ii)&nbsp;interfering in any way with the right of the Company or an Affiliate to terminate any Eligible Person&#146;s or Participant&#146;s employment or service at any time, (iii)&nbsp;giving an Eligible Person or
Participant any claim to be granted any Award under the Plan or to be treated uniformly with other Participants and employees, or (iv)&nbsp;conferring on a Participant any of the rights of a stockholder of the Company unless and until the
Participant is duly issued or transferred shares of Stock in accordance with the terms of an Award. Neither the Plan nor any action taken hereunder shall be construed to alter the status of any Eligible Person or Participant as an employee at will.
Except as expressly provided in the Plan or an Award Agreement, neither the Plan nor any Award Agreement shall confer on any person other than the Company and the Participant any rights or remedies thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.16</B>&#8195;&#8194;&#8196;<B>Severability; Entire Agreement</B>. If any of the provisions of this Plan or any Award Agreement are
finally held to be invalid, illegal or unenforceable (whether in whole or in part), such provision shall be deemed modified to the extent, but only to the extent, of such invalidity, illegality or unenforceability, and the remaining provisions shall
not be affected thereby; provided, that, if any of provision of a restrictive covenant applicable to an Award pursuant to Section&nbsp;10.01 (a &#147;Restrictive Covenant&#148;) is finally held to be invalid, illegal, or unenforceable because it
exceeds the maximum scope determined to be acceptable to permit such provision to be enforceable, such provision shall be deemed to be modified to the minimum extent necessary to modify such scope in order to make such provision enforceable
hereunder; and further provided that if any portion of a Restrictive Covenant is finally held to be invalid, illegal or unenforceable notwithstanding such modification or because such modification of the acceptable scope does not cure such
invalidity, illegality or unenforceability, such provision shall not be severable, the entire Award shall be deemed invalid, illegal and unenforceable; the Company and its Affiliates shall have no liability or obligation respecting such Award, and
the Participant shall forthwith restore to the Company any payment or settlement previously made pursuant to that Award. The Plan and any Award Agreements contain the entire agreement of the parties with respect to the subject matter thereof and
supersede all prior agreements, promises, covenants, arrangements, communications, representations and warranties between them, whether written or oral with respect to the subject matter thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.17</B>&#8195;&#8194;&#8196;<B>Plan Term</B>. Unless earlier terminated by action of
the Board, the Plan will remain in effect until such time as no Stock remains available for delivery under the Plan, and the Company has no further rights or obligations under the Plan with respect to outstanding Awards under the Plan; subject to
Section&nbsp;7.01(c)(iii) regarding Incentive Stock Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.18</B>&#8195;&#8194;&#8196;<B>Gender and Number</B>. Except when
otherwise indicated by the context, the masculine gender shall also include the feminine gender, and the definitions of any term herein in the singular shall also include the plural. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><B>10.19</B>&#8195;&#8194;&#8196;<B>General Creditor Status</B>. With respect to any Award other than Restricted Stock Shares, each
Participant and Beneficiary shall be and remain an unsecured general creditor of the Company with respect to any payments due and owing to such Participant or Beneficiary hereunder. All payments to persons entitled to benefits hereunder shall be
made out of the general assets of the Company and shall be solely the obligation of the Company. To the extent the Plan is a promise by the Company to pay benefits in the future and it is the intention of the Company and Participants that the Plan
be &#147;unfunded&#148; for tax purposes (and for the purposes of Title I of the Employee Retirement Income Security Act of 1974, as amended). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>wba-20250130.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 2/6/2025 2:31:01 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:wba="http://walgreensbootsalliance.com/20250130"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://walgreensbootsalliance.com/20250130"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" namespace="http://fasb.org/us-types/2024" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wba-20250130_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wba-20250130_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wba-20250130_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="wba_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="wba_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" name="M3.600WalgreensBootsAllianceInc.NotesDue2025Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" name="M2.125WalgreensBootsAllianceInc.NotesDue2026Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>wba-20250130_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 2/6/2025 2:31:04 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="wba-20250130.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="wba-20250130.xsd#wba_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="wba-20250130.xsd#wba_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="wba-20250130.xsd#wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" xlink:type="locator" xlink:label="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" />
    <link:loc xlink:href="wba-20250130.xsd#wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" xlink:type="locator" xlink:label="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="wba_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="30.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="52.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="53.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>wba-20250130_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 2/6/2025 2:31:01 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="wba-20250130.xsd#wba_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="wba_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="wba-20250130.xsd#wba_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="wba_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="wba-20250130.xsd#wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" xlink:type="locator" xlink:label="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" xlink:to="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">M 3.600 Walgreens Boots Alliance Inc . Notes Due 2025 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">M 3.600 Walgreens Boots Alliance Inc . Notes Due 2025 [Member]</link:label>
    <link:loc xlink:href="wba-20250130.xsd#wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" xlink:type="locator" xlink:label="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" xlink:to="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">M 2.125 Walgreens Boots Alliance Inc . Notes Due 2026 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">M 2.125 Walgreens Boots Alliance Inc . Notes Due 2026 [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>wba-20250130_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 2/6/2025 2:31:02 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="wba-20250130.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="wba-20250130.xsd#wba_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="wba_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="wba-20250130.xsd#wba_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="wba_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="wba-20250130.xsd#wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" xlink:type="locator" xlink:label="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="wba-20250130.xsd#wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" xlink:type="locator" xlink:label="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="53.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46188032241936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001618921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 30,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WALGREENS BOOTS ALLIANCE, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-1758322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">108 Wilmot Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Deerfield<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(847)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">315-3700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WBA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member', window );">M 3.600 Walgreens Boots Alliance Inc . Notes Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">3.600% Walgreens Boots Alliance, Inc. notes due 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WBA25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member', window );">M 2.125 Walgreens Boots Alliance Inc . Notes Due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">2.125% Walgreens Boots Alliance, Inc. notes due 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WBA26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wba_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wba_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wba_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MP$7LJ<UP*WB^$:1[!']A:8,$WA&A'FW_NWD3V I 6@#27"^H AR4 I)/5]"
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M4&HXBHNG $^3PXNM0JBRV(*=ET]X+ET3VO"A?+ZDV#IHL>$7?.ML=0$6O&^
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ &(1%6I>*NQS
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M=1,92L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3
MQFU+BLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=
MR_$)'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D
M&IND53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&
ML&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @
M&(1%6B0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
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M&G_FB^$_7G\!4$L! A0#%     @ &(1%6@=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  8A$5:DV<O
MTN\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    "  8A$5:F5R<(Q &  "<)P  $P              @ '- 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !B$15H('$R+4 4  ((9
M   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    "  8A$5:GZ ;\+$"  #B#   #0              @ &4#0
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( !B$15J7BKL<P    !,"   +
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4!08     "0 ) #X"  #T%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d896789d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d896789d8k.htm">d896789d8k.htm</File>
    <File>wba-20250130.xsd</File>
    <File>wba-20250130_def.xml</File>
    <File>wba-20250130_lab.xml</File>
    <File>wba-20250130_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d896789d8k.htm": {
   "nsprefix": "wba",
   "nsuri": "http://walgreensbootsalliance.com/20250130",
   "dts": {
    "inline": {
     "local": [
      "d896789d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "wba-20250130.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "wba-20250130_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "wba-20250130_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wba-20250130_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 31,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 29
   },
   "report": {
    "R1": {
     "role": "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-01-30_to_2025-01-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d896789d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-01-30_to_2025-01-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d896789d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "wba_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://walgreensbootsalliance.com/20250130",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wba_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://walgreensbootsalliance.com/20250130",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://walgreensbootsalliance.com/20250130",
     "localname": "M2.125WalgreensBootsAllianceInc.NotesDue2026Member",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "M 2.125 Walgreens Boots Alliance Inc . Notes Due 2026 [Member]",
        "terseLabel": "M 2.125 Walgreens Boots Alliance Inc . Notes Due 2026 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://walgreensbootsalliance.com/20250130",
     "localname": "M3.600WalgreensBootsAllianceInc.NotesDue2025Member",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "M 3.600 Walgreens Boots Alliance Inc . Notes Due 2025 [Member]",
        "terseLabel": "M 3.600 Walgreens Boots Alliance Inc . Notes Due 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://walgreensbootsalliance.com//20250130/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-25-020848-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-020848-xbrl.zip
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MW'/&7+_C>8%/'<>FKLD*IM?'3I1D19.3!OGVO.9 %4KQKV^7;;/'^C1ONWZ
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M3_TQLU28]_<72?/B7.-6M+UY4ARUV=UCE)RRE"AD%$SC-&=T !K6XP+NB5^
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M(2S^,ZJJU_+$V(NDA!U#511ZYY'\=^T\V$L&JW'+Q:'1?)XGF1"W%T&<2I0
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MB+K)* <G6Q(K\(VVOPEX0]_!8,"XR! 4AX8+W ,MC@(C5<HW\:SK,1R@5W!
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M30>]93-L_JJ#TK[SZYWD9.T.!^Z!WGET<_JB]5"W6N5:2EQH!7!U;<+K)LV
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M;+UEZ"/3U)++^<OE^C#1$LX9',RKO;\1U7A>:#P)0WIA%"-Z4\+P.\]OI0(
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M(\SBR4?IEKUFMH[!3*[Z'#[]6VAEN2,R83$;TPMUG81-/Q %TSH;VPY"BQ*
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MNMAJTVFTB2QB:N=2.RHLN6L5VMW -+Y'NM!<FG*UMH:W)5=1-[LFOE*-U$$
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M]T.]CXY,F=MB;E%7K7++#;Y,W;/B)@TU,KB1.#-A$_;\BD1LL1L6#2+0^(W
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MK%T<Q+\*-^ )YZ$8^BIM*EMT[0=NC%G7<$::*IR.C0V%??\DVN.O6(#\YKX
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M+Y@*9$7?H\\7Q=W1-XF[)T<?L^!! $!A8C;#(',#+M"RUD%[O\7X;KC+!MQ
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MM4[EG-F$I,:RK'$A(R T2+M.:;]WS%[4#VRQ:-\,[JY94^U'-P(XE$(&$^0
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MV^7 *R2U=+&\%-T=9%(4Y3KNX1%"(!XJD@'^EZ=_P$OZ7X3_!U!+ P04
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M_)/CO?@_F2G?(!(EKU\;3&\P'EX3R7C>S+UFN7]=5LA7]68W3UP>CG8ZWAQ
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M\&-_<+07C>.-!!R _)X):(YX\Z3"GU\ 4$L#!!0    ( !B$15JG,/+U!P8
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MG$81U]\.JK_D]!.F3)ZMF$YTU_.AR!V=)7CL!#P4P>?\X=!J1!ZZ E,?GAH
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M'F>9KR +[:UA?OFVFF^*_##R6V%C*1/OG6ERG57!*=S#&)G/3_?]KVUB.A$
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M.38W.#ED.&LN:'1M4$L! A0#%     @ &(1%6FA*37!LE0  =#8$ !$
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M              "  1'/  !W8F$M,C R-3 Q,S!?<')E+GAM;%!+!08
.!P ' +T!   )U0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>d896789d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:wba="http://walgreensbootsalliance.com/20250130"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="wba-20250130.xsd" xlink:type="simple"/>
    <context id="duration_2025-01-30_to_2025-01-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <context id="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <context id="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:M3.600WalgreensBootsAllianceInc.NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <context id="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:M2.125WalgreensBootsAllianceInc.NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-613">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-01-30_to_2025-01-30"
      id="Hidden_dei_EntityCentralIndexKey">0001618921</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2025-01-30_to_2025-01-30"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2025-01-30_to_2025-01-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-649">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-650">2025-01-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-651">WALGREENS BOOTS ALLIANCE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-652">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-653">001-36759</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-654">47-1758322</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-655">108 Wilmot Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-656">Deerfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-657">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-658">60015</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-659">(847)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-660">315-3700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-661">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-662">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-663">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-664">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-665">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-666">WBA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-667">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member"
      id="ixv-668">3.600% Walgreens Boots Alliance, Inc. notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member"
      id="ixv-669">WBA25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member"
      id="ixv-670">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member"
      id="ixv-671">2.125% Walgreens Boots Alliance, Inc. notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member"
      id="ixv-672">WBA26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-01-30_to_2025-01-30_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member"
      id="ixv-673">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-01-30_to_2025-01-30" id="ixv-674">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
